At our third quarter 2026 financial results call, CEO Dr. Jacqueline Shea provided an overview of INOVIO’s transition to a commercial stage company and plans to maximize the opportunity ahead. Highlights included:
-Recap of recent FDA Accelerated Approval of INOVIO’s plasmid DNA-based immunotherapy for adults with RRP
-Overview of commercial launch plans and significant market opportunity
-Strategy for leveraging the validation of INOVIO’s #dnamedicine platform
The webcast will be available for 90 days, watch the replay here: app.webinar.net/r4q6KeZpbD1
Inovio Pharmaceuticals
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development (June 2020). More on Wikipedia
-
INOVIO Pharmaceuticals
@InovioPharma
-
INOVIO Pharmaceuticals
@InovioPharma
Our team will participate in two upcoming investor conferences, where management will discuss our recently approved product to treat adults with Recurrent Respiratory Papillomatosis (#rrp) and other business developments:
* Jefferies Global Healthcare Conference in London on November 18 at 12:00PM EST / 5:00PM GMT
* Piper Sandler 38th Annual Healthcare Conference in New York on December 1 at 2:00PM EST
For webcast links and more details, read the full announcement: ir.inovio.com/news/news-details/2026/INOVIO-to-Participat…
#dnamedicines #rarediseases -
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports financial results and operational highlights for the third quarter of 2026 - read more here: ir.inovio.com/news/news-details/2026/INOVIO-Reports-Third…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO will report third quarter 2026 financial results on Tuesday, November 10 after market close. Management will host a conference call at 4:30 p.m. ET to discuss results and provide a business update. Join the live webcast using the link below or access the replay in the Events & Presentations section of our IR site:
app.webinar.net/r4q6KeZpbD1
#dnamedicines #q32026 -
INOVIO Pharmaceuticals
@InovioPharma
The approval of our first plasmid DNA-based immunotherapy represents a pivotal moment for INOVIO and offers hope to the many RRP patients who continue to suffer from the relentless cycle of surgery. Watch a replay of our approval investor call here: app.webinar.net/6LNlx7kxyqd
-
INOVIO Pharmaceuticals
@InovioPharma
Tune in to our live webcast today at 8am ET to learn about the FDA accelerated approval of INOVIO’s plasmid DNA-based immunotherapy for RRP: app.webinar.net/6LNlx7kxyqd
-
INOVIO Pharmaceuticals
@InovioPharma
BREAKING NEWS: INOVIO has announced the FDA accelerated approval of its plasmid DNA-based immunotherapy to reduce the frequency of surgery in adults with Recurrent Respiratory Papillomatosis (#rrp), a rare, debilitating HPV-related disease. The approval represents a major milestone for the RRP community and for INOVIO.
Read the full announcement here: ir.inovio.com/news/news-details/2026/INOVIO-Announces-FDA…
Join a live webcast on Monday, November 2, to learn more about the approval: app.webinar.net/6LNlx7kxyqd -
INOVIO Pharmaceuticals
@InovioPharma
DYK: Everyone has the BRCA1 & BRCA2 genes, but people with mutations on those genes face an increased risk for breast cancer and other BRCA-related cancers. Researchers at @BasserBRCA are investigating if an INOVIO #dnamedicine can help protect people with these mutations by recognizing the earliest signs of disease and stopping #breastcancer before it develops. The trial is underway and represents the power of partnerships to advance innovative cancer research. Read more about their work and the people with a family history of BRCA-related cancer who volunteered to help advance cancer research: www.pennmedicine.org/news/volunteers-for-cancer-preventio…
#breastcancerawarenessmonth #breastcancerawareness -
INOVIO Pharmaceuticals
@InovioPharma
Pleased to share that INOVIO management will be participating in several upcoming investor conferences, featuring webcast presentations and one-on-one investor meetings. Details are available on INOVIO’s events page: ir.inovio.com/events-and-presentations/default.aspx
-
INOVIO Pharmaceuticals
@InovioPharma
At our second quarter 2026 financial results call, CEO Dr. Jacqueline Shea highlighted important regulatory progress and commercial preparations for lead candidate INO-3107 as the company works towards its October target PDUFA date. To hear more on this and other corporate highlights, you can listen to the webcast replay here: app.webinar.net/EObGLbd2owY
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports financial results and operational highlights for the second quarter of 2026 – read more here: ir.inovio.com/news/news-details/2026/INOVIO-Reports-Secon…
-
INOVIO Pharmaceuticals
@InovioPharma
DYK that HPV causes 60-70% of all throat cancer? And that HPV-positive throat cancer is the most commonly diagnosed HPV-related cancer in the US? With cases on the rise and few treatment options for patients with advanced disease, #teaminovio is researching how to leverage the T cell-generating power of DNA medicine in combination with a PD-1 checkpoint inhibitor to change the treatment paradigm for this HPV-related cancer. #worldheadandneckcancerday
-
INOVIO Pharmaceuticals
@InovioPharma
On #gbmday we stand with the patients, families and caregivers whose lives have been impacted by Glioblastoma - the most common and deadly type of brain cancer. Supporting a critical need for new, effective treatments, #teaminovio is forging innovative partnerships to advance promising DNA medicine candidates targeting GBM – read more here: ir.inovio.com/news/news-details/2026/INOVIO-and-Akeso-Ann…
#glioblastoma #gbm @NBTStweets -
INOVIO Pharmaceuticals
@InovioPharma
DYK that #rrp is caused by strains 6 & 11 of the human papillomavirus (HPV)? So today – 6/11 – we’re spreading awareness about this debilitating rare disease and the urgent need for treatment options that can help every patient reduce their need for surgery. #teaminovio is proud to support the Recurrent Respiratory Papillomatosis Foundation in their efforts to amplify patient voices - because every surgery matters, every patient matters, and every patient deserves a treatment that works for them.
-
INOVIO Pharmaceuticals
@InovioPharma
See you at #wodc 2026! INOVIO will be there to highlight promising research on rare disease protein replacement therapeutics and the transformational potential of our next-gen DNA medicine technology.
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is pleased to be participating in the upcoming 2026 Jefferies Global Healthcare Conference, where we’ll be discussing progress with lead candidate INO-3107 for #rrp and other highlights from our DNA medicine pipeline. Webcast available here: event.summitcast.com/view/NgCqua4VVQjq9ibVWHVWca/adRiTkvK…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is pleased to be at #asco26 this week to share additional data demonstrating how lead candidate INO-3107 for #rrp elicits a targeted immune response that is associated with improved clinical outcomes for patients. Read the abstract here: ir.inovio.com/events-and-presentations/event-details/2026…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO’s partner ApolloBio announced positive topline results from a Phase 3 trial in China for VGX-3100 in patients with cervical dysplasia. The results further highlight the potential of #dnamedicine to treat HPV-related diseases, eliminating or reducing the need for surgical interventions. Read more: ir.inovio.com/news/news-details/2026/Positive-Topline-Res…
-
INOVIO Pharmaceuticals
@InovioPharma
At our first quarter 2026 financial results call, CEO Dr. Jacqueline Shea reiterated INOVIO’s strategic focus on advancing lead candidate INO-3107 through the regulatory process and delivering on the promise of DNA medicine for RRP patients. To hear more on this and other corporate highlights, you can listen to the webcast replay here: app.webinar.net/LJpjgyEg2Oa
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports financial results and operational highlights for the 1st quarter of 2026 – read more here: ir.inovio.com/news/news-details/2026/INOVIO-Reports-First…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is excited to be at #asgct2026 this week to highlight preclinical data from our next-gen DPROT technology for the treatment of Hemophilia A. Our research shows that DRPOTs have the potential to drive sustained production of complex proteins within the body and could be applicable to a wide range of rare protein-replacement diseases. Learn more about our next-gen technology here: inovio.com/dna-medicines-technology/
-
INOVIO Pharmaceuticals
@InovioPharma
It's #graymay, a month dedicated to raising awareness about brain tumors, their impact on patients, and the critical importance of research to improve brain tumor diagnosis and treatment. #teaminovio’s focus: glioblastoma, the most common and aggressive form of brain cancer. According to the National Cancer Institute, about 15,000 people are diagnosed with glioblastoma each year and GBM patients are in desperate need of new treatment options to improve their prognosis. INOVIO is working with partners to develop innovative cancer immunotherapies to treat GBM that leverage the power of DNA medicine. Read more: ir.inovio.com/news/news-details/2026/INOVIO-and-Akeso-Ann…
#btam -
INOVIO Pharmaceuticals
@InovioPharma
Happy #dnaday! Today we’re celebrating the tiny powerhouses of our platform: precisely designed plasmids. These small circular DNA molecules work like software that the body’s cells can download to produce specific proteins to target and fight disease. Our optimized plasmids enable our DNA medicines to drive tailored and sustained protein expression within the body, generating antigen-specific T cells to target cancers or viral infections, monoclonal antibodies for disease prevention or treatment, or therapeutic levels of protein expression for disease control in enzyme or protein replacement diseases. #teaminovio is leveraging that versatility to develop DNA medicines that could transform the way we treat and prevent disease around the world.
-
INOVIO Pharmaceuticals
@InovioPharma
Pleased to share that data linking the long-term efficacy of lead candidate INO-3107 for #rrp with the immunological response observed at Year 1 in our Phase 1/2 trial will be featured this week at #2026cosm, the premier forum for experts in the field of otolaryngology. Learn more: ir.inovio.com/events-and-presentations/event-details/2026…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO will be at the world’s largest international conference on bleeding disorders this week to highlight preclinical data from our next gen DPROT technology targeting hemophilia A. Key takeaways: DRPOTs show potential to drive sustained production of complex proteins within the body, a strength that could be beneficial in a wide range of rare protein-replacement diseases. #wfhworldcongress
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO will be at the world’s largest international conference on bleeding disorders next week to highlight preclinical data from our next-gen DPROT technology targeting Hemophilia A. Key takeaways: the data show the exciting potential for long term FVIII secretion from a non-viral-vector platform, and the ability to drive sustained production of complex proteins within the body is a strength that could be leveraged to develop innovative new treatments for Hemophilia and other rare diseases like Fabry and Hypophosphatasia. #wfhworldcongress
-
INOVIO Pharmaceuticals
@InovioPharma
Hemophilia is a life-long, chronic condition requiring treatment that’s often costly and difficult. #teaminovio is working on DNA Medicines that could be a game changer for people with Hemophilia A and other rare diseases by giving their body the tools to treat their disease from within. Our goal: leverage our platform’s ability to drive sustained in vivo production of complex proteins and develop innovative new hemophilia treatments for patients around the world. #whd2026
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is headed to #wvcdc, where we’ll be highlighting the breakthrough potential of our next-gen DNA medicine technology, with a focus on DMAbs and the in vivo expression of complex proteins like monoclonal antibodies. Read more about the proof-of-concept Phase 1 trial here:
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is excited to be presenting at #eurogin, the world’s leading international congress on HPV infection and associated cancers, where we’ll highlight lead candidate INO-3107 and its potential to provide long term clinical benefit to #rrp patients.
-
INOVIO Pharmaceuticals
@InovioPharma
At our quarterly financial results call, CEO Dr. Jacqui Shea discussed INOVIO’s regulatory progress with lead candidate INO-3107 for #rrp and INOVIO’s commitment to delivering on the promise of DNA medicine for patients. To hear more on this and other corporate highlights, you can listen to the webcast replay here: ir.inovio.com/news/news-details/2026/INOVIO-Reports-Fourt…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports financial results and operational highlights for the 4th quarter & full year of 2025 – read more here: ir.inovio.com/news-releases/news-releases-details/2026/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
As a rare disease, #rrp doesn’t always make it into conversations about HPV. Last year INOVIO was proud to sponsor an opportunity for the RRP Foundation to connect with the @HPVAlliance – listen to their conversation about the RRP patient experience and importance of bringing RRP into the broader HPV-related cancer community: www.youtube.com/watch?v=V5G6Gfi-IKI #hpvawarenessday
-
INOVIO Pharmaceuticals
@InovioPharma
Pleased to announce a new clinical collaboration to advance a novel combination treatment for #gbm, a rare & devastating brain cancer. Researchers will evaluate INOVIO's INO-5412 with @AkesoInc 's first-in-class PD-1/CTLA-4 bispecific antibody cadonilibmab. Read more: ir.inovio.com/news/news-details/2026/INOVIO-and-Akeso-Ann…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO will be at the @Festofbiologics to highlight the breakthrough potential of DMAbs as a long-acting, scalable & tolerable alternative to traditional delivery of monoclonal antibodies. Read more about the proof-of-concept Phase 1 trial here: ir.inovio.com/news/news-details/2025/Clinical-Proof-of-Co…
-
INOVIO Pharmaceuticals
@InovioPharma
Glioblastoma (GBM) is a #raredisease and the most common and aggressive form of brain cancer. According to the National Cancer Institute, about 15,000 people are diagnosed with glioblastoma each year and GBM patients are in desperate need of new treatment options to improve their prognosis. INOVIO is working with partners to develop innovative cancer immunotherapies that leverage the power of DNA medicine.
-
INOVIO Pharmaceuticals
@InovioPharma
Hemophilia A is an inherited bleeding disorder stemming from a genetic mutation on the X chromosome. That means men are predominantly affected, and 33,000 males are estimated to be living with hemophilia in the United States. It’s a life-long, chronic condition requiring treatment that’s often costly and difficult for patients. In preclinical studies, INOVIO’s next generation DPROT technology has demonstrated the ability to induce long-term protein secretion that could be a game-changer for Hem A and other #raredisease that could be treated with in vivo protein replacement therapy. Learn more: ir.inovio.com/events-and-presentations/event-details/2025…
-
INOVIO Pharmaceuticals
@InovioPharma
For #rrp patients, every surgery comes with a risk and a cost. Some face 100s of surgeries over a lifetime. But with every single RRP patient in mind, we’re working to change the treatment paradigm for this rare and devastating HPV-related disease. Read more here: inovio.com/pipeline/current-pipeline/ #rarediseaseday
-
INOVIO Pharmaceuticals
@InovioPharma
On #rarediseaseday, we stand with the millions of people affected by rare diseases as they inspire our work every day. #teaminovio is committed to leveraging the power of DNA medicine to advance new, innovative therapies for devastating diseases such as RRP, Hemophilia, and GBM. Follow us here as we shine a light on rare disease and help make sure rare doesn’t mean forgotten.
-
INOVIO Pharmaceuticals
@InovioPharma
At upcoming investor conferences, INOVIO will be discussing its lead candidate, INO-3107, as a potential treatment for RRP and recent data from our #dnamedicine pipeline. Find links to the webcasts on our events page: ir.inovio.com/events-and-presentations/default.aspx
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO will highlight immunology data for lead candidate INO-3107 for #rrp at #aacrio26 this week. Key takeaway: INO-3107 induced activation & enrichment of pro-inflammatory CD4+T cell responses that were associated with clinical response (reduction in surgery) in a Ph 1/2 trial.
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO will be presenting pre-clinical data from its DPROT technology targeting hemophilia A at the upcoming @FoGenomics conference, highlighting a key strength of our #dnamedicine platform: the ability to drive sustained, targeted protein production within the body.
-
INOVIO Pharmaceuticals
@InovioPharma
Heading to #jpm2026? INOVIO will be in San Francisco next week – looking forward to connecting with investors and potential partners who want to learn more about the power and promise of DNA medicine.
-
INOVIO Pharmaceuticals
@InovioPharma
The FDA has accepted for review INOVIO’s BLA for lead candidate INO-3107 for the treatment of #rrp in adults, setting a PDUFA action date for October 30, 2026. Read more here: ir.inovio.com/news/news-details/2025/FDA-Accepts-for-Revi…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO presented promising pre-clinical data on our DPROT technology targeting hemophilia A at the #wfhglobalforum, highlighting a key strength of our DNA medicine platform: the potential to drive sustained, targeted protein production within the body. ir.inovio.com/events-and-presentations/event-details/2025…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is pleased to join the upcoming #wfhglobalforum to discuss the potential promise of next-gen DNA medicine, including exciting preclinical work showing the potential to expand into in vivo production of therapeutic proteins to address Hemophilia A & other rare diseases.
-
INOVIO Pharmaceuticals
@InovioPharma
Chief Medical Officer Dr. Mike Sumner shared his thoughts on the potential he sees for lead candidate INO-3107 for #rrp at INOVIO’s 3Q25 financial results call. Watch the replay here: app.webinar.net/LarDXQGoR3Z
-
INOVIO Pharmaceuticals
@InovioPharma
At our 3Q25 financial results call, CEO Dr. Jacqueline Shea discussed pivotal progress for lead candidate INO-3107 for #rrp and other corporate highlights. You can find a replay of the full webcast here: app.webinar.net/LarDXQGoR3Z
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports financial results and operational highlights from the third quarter of 2025 – read more here: ir.inovio.com/news/news-details/2025/INOVIO-Reports-Third…
-
INOVIO Pharmaceuticals
@InovioPharma
Congratulations to Dr. Vonderheide! His research on a cancer-intercepting DNA medicine candidate from INOVIO could be groundbreaking for breast cancer treatment and prevention.
Penn Medicine
@PennMedicine
Robert Vonderheide, MD, DPhil, @PennCancer, has been honored with the @BCRFcure’s 2025 Jill Rose Award for Scientific Excellence, the foundation’s highest scientific honor. www.pennmedicine.org/news/breast-cancer-research-foundati…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO has completed its BLA submission for INO-3107 – a major milestone in our efforts to deliver on the promise of DNA medicine for #rrp patients. If approved, INO-3107 would be INOVIO’s 1st commercial product & the 1st DNA medicine available in the US ir.inovio.com/news/news-details/2025/INOVIO-Completes-Rol…
-
INOVIO Pharmaceuticals
@InovioPharma
At the 2025 @Int_S_Vaccines Annual Conference we’re shining a spotlight on the potential of lead candidate INO-3107 to deliver on the promise of DNA medicine for #rrp patients. Read the abstract here: ir.inovio.com/events-and-presentations/event-details/2025…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is excited to present at the #wodc! This is the largest orphan drug and rare disease event in the US. We’ll be highlighting the potential of our next gen DMAb technology to help develop and advance life-saving therapies for rare disease patients.
-
INOVIO Pharmaceuticals
@InovioPharma
At #ipvs2025 we’re discussing how every #rrp patient deserves a treatment that works for them. In a Phase 1/2 trial, INO-3107 reduced surgeries for the majority of patients - irrespective of the papilloma microenvironment. Read the abstracts: ir.inovio.com/events-and-presentations/event-details/2025…
-
INOVIO Pharmaceuticals
@InovioPharma
Exciting news for our next-gen DNA-Encoded Monoclonal Antibody (DMAb) technology: clinical proof-of-concept data from a Phase 1 trial was published in Nature Medicine, including complete data for all participants up to week 72. Read more: ir.inovio.com/news/news-details/2025/Clinical-Proof-of-Co…
-
INOVIO Pharmaceuticals
@InovioPharma
At #esmo25 we're sharing data demonstrating how our lead investigational candidate INO-3107 could potentially change the treatment paradigm for #rrp. Our goal: make surgery a last resort, not a first line treatment . Read more: ir.inovio.com/events-and-presentations/event-details/2025…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is at #wvceu25 this week to present on the power & potential of DNA medicine, including data on the long-term efficacy of lead investigational candidate INO-3107 for Recurrent Respiratory Papillomatosis (#rrp) and a presentation on our next-gen DMAb technology.
-
INOVIO Pharmaceuticals
@InovioPharma
For #rrp patients, every surgery matters. At #otomtg25, INOVIO is sharing data showing that the majority of patients in a Ph 1/2 trial needed fewer surgeries after treatment w/ INO-3107 & showed continued improvement through YR 2, without additional doses. ir.inovio.com/events-and-presentations/event-details/2025…
-
INOVIO Pharmaceuticals
@InovioPharma
The FDA has agreed to the rolling submission timeline for INOVIO’s BLA for lead candidate INO-3107. INOVIO remains on track to complete submission in 2H25, with the goal of FDA file acceptance by YE25. Read more: ir.inovio.com/news/news-details/2025/INOVIO-to-Begin-Roll…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO management will be participating in the H.C. Wainwright 27th Annual Global Investment Conference with a webcast presentation and one-on-one investor meetings. You can watch the presentation online starting September 5 at 7AM ET: journey.ct.events/view/c0cc4d12-f619-4d58-878f-4ee305e4f2c2
-
INOVIO Pharmaceuticals
@InovioPharma
Important news for the #rrp community: A new peer-reviewed study illustrated the on-going clinical effect of INO-3107, demonstrating how it could provide relief from the risks & costs of surgery & potentially change the trajectory of the disease: ir.inovio.com/news/news-details/2025/Data-Published-in-Th…
-
INOVIO Pharmaceuticals
@InovioPharma
At our 2Q25 financial results call, CEO Dr. Jacqueline Shea shared key updates on INOVIO’s progress with lead candidate INO-3107 for #rrp– you can find a replay of the full webcast here: app.webinar.net/B58P6k9XEDO
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports financial results and operational highlights from the second quarter of 2025 – read more here: ir.inovio.com/news/news-details/2025/INOVIO-Reports-Secon…
-
INOVIO Pharmaceuticals
@InovioPharma
Peer-reviewed data from a retrospective study demonstrated how INO-3017 could transform the treatment paradigm for #rrp patients by providing ongoing clinical benefit of fewer surgical interventions. Read more: ir.inovio.com/news/news-details/2025/Data-Published-in-Th…
-
INOVIO Pharmaceuticals
@InovioPharma
Newly published clinical data shows the majority of #rrp patients treated with INO-3107 maintained or improved upon their clinical response 2 years after initial treatment, without additional dosing: ir.inovio.com/news/news-details/2025/Data-Published-in-Th…
-
INOVIO Pharmaceuticals
@InovioPharma
Glioblastoma is the most common, complex, treatment-resistant & deadly type of brain cancer. On #gbmday we stand with patients & families and look forward to advancing INO-5401, a promising DNA medicine candidate to fight this devastating disease.
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO will be in Boston at the 2nd annual Orphan Drug Summit to present on the transformational potential of our DMAb technology in the rare disease space. Looking forward to connecting with other orphan drug innovators! Read more here: ir.inovio.com/news-releases/news-releases-details/2025/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO was proud to sponsor this important conversation and provide an opportunity for the RRPF to connect with the HPV-related cancer community at @HPVAlliance!
HPV Cancers Alliance
@HPVAlliance
Don’t miss this important conversation about RRP – an HPV-related disease that we need to be talking about‼️
🎥: youtu.be/V5G6Gfi-IKI
#hpvcancersalliance #endhpvcancers (1/2) -
INOVIO Pharmaceuticals
@InovioPharma
Every surgery #rrp patients face comes with significant risk and cost, so every surgery matters. Our goal: develop a non-surgical treatment option that targets the HPV strains that cause RRP and ultimately reduce or eliminate the need for more surgery.
-
INOVIO Pharmaceuticals
@InovioPharma
HPV 6 & 11 are the strains of the human papillomavirus that cause #rrp. Today – 6/11– take a moment to learn more about how our lead DNA medicine candidate targeted these strains and reduced the need for surgery in our Ph 1/2 clinical trial: ir.inovio.com/news/news-details/2025/Clinical-and-Immunol…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is excited to join more than 20K biotech industry leaders from across the globe at the 2025 BIO International Convention. Looking forward to discussing industry trends and building relationships – contact us through the partnering system if you’d like to connect! #bio2025
-
INOVIO Pharmaceuticals
@InovioPharma
Congratulations to Dr. Domchek, whose research includes the cancer-prevention potential of #dnamedicinein people with BRCA1/2 mutations.
BasserBRCA
@BasserBRCA
Dr. Susan Domchek is presented with the 2025 @ASCO-American Cancer Society Cancer Prevention Award as a distinguished expert who has made significant contributions to cancer prevention and research. We’re honored to have her at the forefront of cancer prevention research!
-
INOVIO Pharmaceuticals
@InovioPharma
CMO Dr. Michael Sumner on the key takeaway from our Phase 1/2 trial of INO-3107 for #rrp, shared recently at scientific conferences. Listen to our 1Q25 financial results call for more insights and updates on INO-3107: app.webinar.net/B58P6k9XEDO
-
INOVIO Pharmaceuticals
@InovioPharma
CEO Dr. Jacqueline Shea shared updates on lead candidate INO-3107 for #rrp on our 1Q25 financial results call – you can find a replay of the full webcast here: app.webinar.net/B58P6k9XEDO.
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports financial results and operational highlights from the first quarter of 2025 – read more here: ir.inovio.com/news/news-details/2025/INOVIO-Reports-First…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO will join nearly 3,000 experts in the field of otolaryngology at #cosm2025, where we’re presenting for the first time data on the long-term clinical effect of lead candidate INO-3107 for #rrp.
-
INOVIO Pharmaceuticals
@InovioPharma
Pleased to announce that data on the efficacy of INOVIO’s lead candidate INO-3107 for #rrp will be in the spotlight at #asgct25, the premier conference for gene and cell therapy research and technology.
-
INOVIO Pharmaceuticals
@InovioPharma
We are pleased to announce that INOVIO will participate in a fireside chat at the upcoming Citizens JMP Life Sciences Conference at 11:30 am ET on May 8. A link to the live webcast or replay of the presentation is available here: ir.inovio.com/events-and-presentations/event-details/2025…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is honored to be presenting highlights from our Ph 1/2 trial of lead candidate INO-3107 for #rrp at the 15th ELS Congress. We look forward to connecting with experts in laryngology from across Europe.
-
INOVIO Pharmaceuticals
@InovioPharma
Happy #dnaday! Today we’re celebrating plasmids: we engineer these circular DNA molecules to work like software that the body’s cells can use to learn how to produce specific proteins to target & fight disease—and they’re the backbone of our #dnamedicines platform.
-
INOVIO Pharmaceuticals
@InovioPharma
Honored to be nominated in the Best Biotech category at the #wvcdc25 18th Annual ViE Awards, which recognize excellence & innovation in the vaccine industry.
-
INOVIO Pharmaceuticals
@InovioPharma
This Head & Neck #cancerawareness month we’re shining a spotlight on HPV+ throat cancer. INOVIO is researching how to leverage the T cell generating power of #dnamedicine in combination with a PD-1 checkpoint inhibitor to change the treatment paradigm for this disease.
-
INOVIO Pharmaceuticals
@InovioPharma
📣DNA medicine in the spotlight this month: upcoming presentations will cover clinical data from our lead candidate for RRP (INO-3107) & our novel DMAb technology, with Inovio also joining other leading voices in HPV research at #nhpvc25. Read more: ir.inovio.com/news-releases/news-releases-details/2025/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports fourth quarter and full year 2024 financial results and operational highlights – read more here: ir.inovio.com/news/news-details/2025/INOVIO-Reports-Fourt…
-
INOVIO Pharmaceuticals
@InovioPharma
CEO Jacqui Shea, PhD on INOVIO’s key strategic priorities for the year ahead. Listen to our financial results conference call here: app.webinar.net/kOlwbAkK7Je
-
INOVIO Pharmaceuticals
@InovioPharma
We’re looking forward to joining innovators from across the globe at #bioeuropespring next week. Reach out through the partnering system if you want to connect and talk about the potential of #dnamedicine!
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is excited to report clinical results from its next-gen DNA medicine technology: Positive interim Ph 1 trial results provide clinical proof-of-concept that functional DNA-encoded monoclonal antibodies (DMAbs) can be durably expressed in humans. ir.inovio.com/news-releases/news-releases-details/2025/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is headed to #eurogin, the world’s leading multidisciplinary HPV conference, to present data from our Phase 1/2 trial of INO-3107 for #rrp. Looking forward to connecting with researchers and clinicians focused on fighting diseases related to human papillomavirus.
-
INOVIO Pharmaceuticals
@InovioPharma
Nearly everyone will get HPV at some point. Most infections clear up on their own, but others can lead to disease. #dnamedicines are designed to teach the body to fight different strains of HPV & could change the treatment paradigm for HPV-related diseases. #hpvawarenessday
-
INOVIO Pharmaceuticals
@InovioPharma
#rrp patients face an avg. of 4 surgeries a year. Some face 100s of surgeries over a lifetime. Today, surgery is the standard of care. But with every single RRP patient in mind, we’re working to change the treatment paradigm for this rare and devastating disease. #rarediseaseday
-
INOVIO Pharmaceuticals
@InovioPharma
On #rarediseaseday we’re shining a light on #rrp & raising awareness for the thousands of patients suffering from this devastating HPV-related disease. Learn more about RRP here: www.nidcd.nih.gov/health/recurrent-respiratory-papillomat…
-
INOVIO Pharmaceuticals
@InovioPharma
Published in Nature Communications: clinical & immunological data for INO-3107 for RRP, supporting its potential to be the preferred product if approved, based on clinical benefit, tolerability & patient-centric dosing regimen where every surgery matters. ir.inovio.com/news/news-details/2025/Clinical-and-Immunol…
-
INOVIO Pharmaceuticals
@InovioPharma
On the 10th annual International Day of Women and Girls in Science, we’re celebrating all the women who have helped advance science to improve the world, and all the future female scientists who will follow in their footsteps. #womeninscience #dnamedicine
-
INOVIO Pharmaceuticals
@InovioPharma
Additional immune response data for lead candidate INO-3107 will be presented as a poster at AACR IO – read more: ir.inovio.com/news-releases/news-releases-details/2025/Im…
-
INOVIO Pharmaceuticals
@InovioPharma
Congratulations to Dr. Domchek! Her research at @BasserBRCA @PennCancer on using #dnamedicine to protect people with BRCA1/2 mutations could be truly groundbreaking for cancer prevention.
Penn Medicine
@PennMedicine
Congratulations to Dr. Susan Domchek @BasserBRCA @PennCancer on being awarded the 2025 ASCO-American Cancer Society Cancer Prevention Award! @ASCO @ConquerCancerFd @AmericanCancer www.pennmedicine.org/news/news-releases/2025/january/susa…
-
INOVIO Pharmaceuticals
@InovioPharma
CEO Jacqui Shea & CMO Mike Sumner will be presenting at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12 at 3:20 PM ET. A link to the live webcast or replay of the presentation is available here: ir.inovio.com/events-and-presentations/default.aspx #opcolifesciences
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO shares anticipated 2025 milestones and 2024 accomplishments—read more here: ir.inovio.com/news/news-details/2025/INOVIO-Highlights-An…
-
INOVIO Pharmaceuticals
@InovioPharma
The INOVIO team was honored to participate at the second-ever @RRPFORG1 RRP Roundtable, where experts, patients and industry representatives came together to discuss innovative ways to advance #rrp research, patient care and advocacy. As a community we are better together!
-
INOVIO Pharmaceuticals
@InovioPharma
Dr. Jeffrey Skolnik was at the @RRPFORG1's 2024 RRP Roundtable this weekend to share an overview of INOVIO’s #dnamedicine platform and our goal to deliver on the promise of DNA medicine for patients suffering from HPV-related diseases like #rrp.
-
INOVIO Pharmaceuticals
@InovioPharma
Hello from Bentonville, AR and the 2024 RRP Roundtable! Looking forward to connecting with #rrp experts, hearing from patient advocates and supporting the @RRPFORG1's mission to improve the lives of RRP patients across the globe.
-
INOVIO Pharmaceuticals
@InovioPharma
New data from a retrospective trial of lead candidate INO-3107 shows that half of #rrp patients treated with INO-3107 achieved a complete response when evaluated 2 and 3 years following the initial Phase 1/2 trial. Details here: ir.inovio.com/news-releases/news-releases-details/2024/Ne…
-
INOVIO Pharmaceuticals
@InovioPharma
CEO Jacqui Shea on the potential she sees for INO-3107 and driving progress for RRP patients. Listen to our financial results conference call here: app.webinar.net/kOlwbAkK7Je
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports third quarter financial results and operational highlights – read more here: ir.inovio.com/news-releases/news-releases-details/2024/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO announces important immunology data corresponding to a reduction of surgeries for #rrp patients observed in Phase 1/2 trial – read more for details: ir.inovio.com/news-releases/news-releases-details/2024/Im…
#ipvc2024 -
INOVIO Pharmaceuticals
@InovioPharma
Dr. Dave Liebowitz will join other industry leaders and visionaries next week at the Vaccines Summit in Boston, MA to give a keynote address on the power and versatility of INOVIO’s #dnamedicine platform.
-
INOVIO Pharmaceuticals
@InovioPharma
Dr. Matthew Morrow and Dr. Jeffrey Skolnik will be sharing new data on INO-3107, our lead candidate for the treatment of #rrp at #ipvc2024 – the leading international platform for sharing cutting-edge HPV research.
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO will be sharing new data and highlighting the versatility of our #dnamedicine platform at upcoming scientific conferences – details here: ir.inovio.com/news-releases/news-releases-details/2024/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Our business development team will be at #bioeurope next week to connect with innovators from across the globe and talk about the potential of #dnamedicine. Reach out through the partnering system if you want to connect in Stockholm!
-
INOVIO Pharmaceuticals
@InovioPharma
See you at #wvceu! Don’t miss Dr. Dave Liebowitz, SVP Early Stage Clinical Development, at the pre-congress workshop on platform technology, where he’ll be discussing the power and potential of #dnamedicine.
-
INOVIO Pharmaceuticals
@InovioPharma
Experts in vaccines and immunotherapy from around the world are gathering next week for the @Int_S_Vaccines Annual Congress. CMO Michael Sumner will be there to present the full safety and efficacy data from INOVIO's Phase 1/2 clinical study of INO-3107 in patients with #rrp.
-
INOVIO Pharmaceuticals
@InovioPharma
Excited to join some of the world’s leading vocal disorder clinicians at @TheFallVoice conference - Dr. Jeffrey Skolnik, SVP Clinical Development, will be there to discuss the full safety and efficacy data from our Ph 1/2 clinical study of INO-3107 in patients with #rrp.
-
INOVIO Pharmaceuticals
@InovioPharma
New data shared at the #aacrtii24 shows that in our Ph 1/2 trial, INO-3107 generated an immune response associated with clinical benefit for #rrp patients. Read more here: ir.inovio.com/news-releases/news-releases-details/2024/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Pleased to announce that Dr. Matthew Morrow will be at the AACR Special Conference in Cancer Research: Tumor Immunology and Immunotherapy this weekend to highlight new immunology data for our lead candidate, INO-3107 for #rrp. #aacrtii24
-
INOVIO Pharmaceuticals
@InovioPharma
Everyone has BRCA1 & BRCA2 genes that play a role in controlling or preventing cancer. But mutations in BRCA1 & BRCA2 genes = increased cancer risk. Researchers at @BasserBRCA asked: Could INOVIO #dnamedicine help protect people with these mutations? #breastcancerawarenessmonth
INOVIO Pharmaceuticals
@InovioPharma
Researchers @BasserBRCA have started looking at how INOVIO #dnamedicine might help people with BRCA1 & BRCA2 mutations by recognizing the earliest signs of disease and stopping #breastcancer before it develops. Read more about their work here: www.inquirer.com/health/penn-brca-cancer-vaccine-trial-20…
-
INOVIO Pharmaceuticals
@InovioPharma
Excited to announce that INOVIO and #dnamedicine will be in the spotlight this fall at several scientific conferences – click here for details: ir.inovio.com/news-releases/news-releases-details/2024/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO #dnamedicine technology will be in the spotlight at the World Congress on Electroporation (@ElecPorationNET) - abstract will be available after the conference at www.inovio.com.
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports second quarter financial results and recent business highlights – read more here: ir.inovio.com/news-releases/news-releases-details/2024/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
The European Medicines Agency's Committee for Advanced Therapies has certified the quality and non-clinical data for INO-3107, INOVIO's lead candidate for the treatment of RRP. Read more: ir.inovio.com/news-releases/news-releases-details/2024/In…
-
INOVIO Pharmaceuticals
@InovioPharma
Help raise awareness on #gbmday to ensure better treatments, a better quality of life, and cures for GBM patients and caregivers. braintumor.org/gbmday
-
INOVIO Pharmaceuticals
@InovioPharma
Help raise awareness on #gbmday to ensure better treatments, a better quality of life, and cures for GBM patients and caregivers. braintumor.org/gbmday
-
INOVIO Pharmaceuticals
@InovioPharma
On #gbmday, INOVIO adds its voice to those raising awareness about #gbm – a deadly, hard-to-treat brain cancer - and the need for more treatment options and improved standards of care for patients suffering from this devastating cancer.
-
INOVIO Pharmaceuticals
@InovioPharma
Leadership update: Steve Egge has been appointed Chief Commercial Officer at INOVIO. He'll lead commercial strategy & operations as we prepare to potentially launch our first DNA medicine product, INO-3107 for #rrp. Read more: ir.inovio.com/news-releases/news-releases-details/2024/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
News from INOVIO: INO-3107 was awarded the Innovation Passport designation under the U.K. government’s Innovative Licensing and Access Pathway. Read more: ir.inovio.com/news-releases/news-releases-details/2024/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO was included in the Russell 2000® Index as part of the annual reconstitution of the Russell stock indexes. Read more here: ir.inovio.com/news-releases/news-releases-details/2024/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
For people with #rrp, the isolation, fear and debilitating impact of their disease is all too real. We’re working to deliver on the promise of #dnamedicine and change the treatment paradigm for RRP and other HPV-related diseases. Learn more: www.inovio.com
-
INOVIO Pharmaceuticals
@InovioPharma
To all of the patients with #rrp who have shared their stories, who are fighting for more treatment options, who are desperate to face even just one less surgery: we hear you.
-
INOVIO Pharmaceuticals
@InovioPharma
For people with #rrp, the isolation, fear and debilitating impact of their disease is all too real. We’re working to deliver on the promise of #dnamedicine and change the treatment paradigm for RRP and other HPV-related diseases. Learn more: www.inovio.com
-
INOVIO Pharmaceuticals
@InovioPharma
6/11: the perfect day to highlight the strains of HPV that cause #rrp! Learn more about how we're designing DNA medicines to target HPV 6 & 11 and change the treatment paradigm for RRP & other HPV-related diseases at www.inovio.com
-
INOVIO Pharmaceuticals
@InovioPharma
For people with #rrp, the isolation, fear & debilitating impact of their disease is all too real. We’re working to deliver on the promise of #dnamedicine & change the treatment paradigm for RRP & other HPV-related diseases. Learn more: www.inovio.com
-
INOVIO Pharmaceuticals
@InovioPharma
Happening next week: CEO Jacqui Shea and CMO Mike Sumner will join a fireside chat for institutional clients of Stephens, Inc. on June 11. Details: ir.inovio.com/news-releases/news-releases-details/2024/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Our business development team will be at the upcoming BIO International Convention to meet with colleagues and talk about the potential of #dnamedicine. Reach out through the BIO partnering system if you want to connect in San Diego! #bio2024
-
INOVIO Pharmaceuticals
@InovioPharma
CEO Jacqui Shea on advancing lead candidate INO-3107 for RRP. Listen to more from our financial results conference call here: app.webinar.net/2k90XB0DWMY
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports first quarter financial results, along with recent operational highlights – read more here: ir.inovio.com/news-releases/news-releases-details/2024/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
🗓️ CEO Jacqui Shea will be at several upcoming investor conferences this month to provide insights on lead candidate INO-3107 and other updates from across our pipeline. Webcasts of the fireside chats will be available - details here: ir.inovio.com/news-releases/news-releases-details/2024/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Happy National #dnaday! Learn more about how we’re harnessing the power and potential of DNA to develop innovative, next generation medicines to fight HPV-related diseases, cancer and infectious diseases: www.inovio.com
-
INOVIO Pharmaceuticals
@InovioPharma
Pleased to be highlighting our work on INO-3107 for #rrp and showcasing the potential of DNA medicine at the upcoming @festofbiologics in San Diego.
-
INOVIO Pharmaceuticals
@InovioPharma
Encouraging results from @GeneosTX, adding to the growing body of research indicating the versatile potential of our DNA medicine platform:
GeneosTX
@GeneosTX
Today, full data from Geneos’ 36-patient Ph 1/2 GT-30 clinical trial were published in @NatureMedicine. The highlight is an ORR of 30.6% in second-line patients with advanced HCC - including 3 CRs and 8 PRs.
www.geneostx.com/geneos-therapeutics-announces-positive-p…
#aacr24 #naturemedicine #hcc #cancervaccine -
INOVIO Pharmaceuticals
@InovioPharma
DYK that HPV causes 70%-80% of all throat cancer in the US? We’re working on a DNA medicine + PD1 checkpoint inhibitor combo therapy for patients with HPV-related throat cancer - read more: ir.inovio.com/news-releases/news-releases-details/2024/IN… Head & neck #cancerawareness
-
INOVIO Pharmaceuticals
@InovioPharma
Head & neck cancers (those inside the mouth, throat, and voice box, for example) account for nearly 4% of all cancers in the US. They're mostly caused by tobacco and alcohol use and infection with the human papilloma virus, or HPV. Get the facts here: www.cancer.gov/types/head-and-neck/head-neck-fact-sheet
-
INOVIO Pharmaceuticals
@InovioPharma
See you at #wvcdc! Dr. Dave Leibowitz, SVP of Early-Stage Clinical Development, will be there to present on DNA-encoded monoclonal antibodies and how they have the potential to improve access to mAb technology.
-
INOVIO Pharmaceuticals
@InovioPharma
Don’t miss Trevor Smith, VP of Preclinical R&D, speaking on next generation #dnamedicine and the development of DNA-launched therapeutics at the International Society for Vaccines webinar series: www.youtube.com/watch?v=hkRnVJKOWgQ
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO will be at #bioeuropespring March 18-20. Looking forward to networking and talking about the power and potential of #dnamedicine at the industry's largest gathering of biopharma professionals in Europe.
-
INOVIO Pharmaceuticals
@InovioPharma
CEO Jacqui Shea on progress made in the past year and what’s on the horizon. Listen to more from our 4Q and full year 2023 financial results conference call here: app.webinar.net/47Nvr2xg3jO
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports fourth quarter and full year 2023 financial results, along with operational highlights – read more here: ir.inovio.com/news-releases/news-releases-details/2024/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
ICYMI: INOVIO recently published important insights on the power and potential of investigational DNA medicine in HPV-related diseases in the journal Molecular Aspects of Medicine. Link to the abstract here: inovio.com/inovio-publications/ #hpvawarenessday
-
INOVIO Pharmaceuticals
@InovioPharma
Patients suffering from HPV-related diseases like RRP need innovative treatment options. Patient voices will be key to changing the treatment paradigm. Read more from CEO Jacqui Shea here: www.linkedin.com/posts/inovio-pharmaceuticals_raredisease… #hpvawarenessday
-
INOVIO Pharmaceuticals
@InovioPharma
ICYMI: Watch the @WhiteHouse #raredisease Forum, featuring perspectives from researchers, regulators and patients, including Kim McClellan from @RRPFORG1: www.youtube.com/watch?v=uG43oLZzeBE
-
INOVIO Pharmaceuticals
@InovioPharma
Thoughts from CEO Jacqueline Shea on the power of patient voices to change the trajectory of rare disease drug development: www.linkedin.com/posts/inovio-pharmaceuticals_raredisease…
#rarediseaseday -
INOVIO Pharmaceuticals
@InovioPharma
Recommended reading for #rarediseaseday: Katie Couric Media highlights one of the strongest and most passionate voices for the RRP community, @RRPF President Kim McClellan: katiecouric.com/health/rare-disease-patient-journey/
-
INOVIO Pharmaceuticals
@InovioPharma
On #rarediseaseday, we celebrate all of the patients with RRP who have shared their stories to advocate for more recognition, research and hope for new treatment options. Today and every day, we hear you.
-
INOVIO Pharmaceuticals
@InovioPharma
Looking forward to joining conversations around the power of collaboration and the importance of patient-centered care at the Multidisciplinary Head and Neck Cancers Symposium today. We're committed to driving innovation in head and neck cancer therapeutics. #hncs24
-
INOVIO Pharmaceuticals
@InovioPharma
On March 6, INOVIO will report 4Q and YE 2023 financial results. Listen to the live conference call and analyst Q&A at 4:30 p.m. ET here: ir.inovio.com/events-and-presentations/default.aspx
-
INOVIO Pharmaceuticals
@InovioPharma
‼️ Happening today: Don’t miss CEO Jacqui Shea at the Oppenheimer 34th Annual Healthcare Life Sciences Conference. Live webcast of the fireside chat will be available starting at 12:40 PM ET here: ir.inovio.com/events-and-presentations/default.aspx #opcolifesciences
-
INOVIO Pharmaceuticals
@InovioPharma
More great coverage of @PennMedicine and @BasserBRCA's groundbreaking study of INO-5401! #dnamedicine #powerofpartnerships
Penn Medicine
@PennMedicine
A groundbreaking cancer vaccine is in the midst of clinical trials at @BasserBRCA. The shot would benefit those carrying cancer-causing #brca gene mutations by recognizing the earliest signs of disease and stopping cancer before it develops.
www.inquirer.com/health/penn-brca-cancer-vaccine-trial-20… -
INOVIO Pharmaceuticals
@InovioPharma
More great coverage of @PennMedicine and @BasserBRCA's groundbreaking study of INO-5401! #dnamedicine #powerofpartnerships
BasserBRCA
@BasserBRCA
A groundbreaking #cancervaccine is in the midst of clinical trials at @PennMedicine's Basser Center. Learn from principal investigator & Basser executive director Susan Domchek, MD & Robert Vonderheide, MD, DPhil, @PennCancer director.
📰 @PhillyInquirer: www.inquirer.com/health/penn-brca-cancer-vaccine-trial-20… -
INOVIO Pharmaceuticals
@InovioPharma
📣CEO Jacqui Shea will be participating in the Oppenheimer 34th Annual Healthcare Life Sciences Conference – tune in Wednesday, February 14 at 12:40 PM ET for a virtual fireside chat. Live webcast will be available here: ir.inovio.com/events-and-presentations/default.aspx #opcolifesciences
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO recently published important insights on the power and potential of DNA medicine in HPV-related diseases in the journal Molecular Aspects of Medicine. Find links to the abstract & other important research from the past year here: inovio.com/inovio-publications/
-
INOVIO Pharmaceuticals
@InovioPharma
Replay from our fireside chat with Oppenheimer and laryngologist Simon Best is now available. Don't miss this important conversation about #rrp and the potential impact of a treatment like INO-3107: ir.inovio.com/events-and-presentations/event-details/2024…
-
INOVIO Pharmaceuticals
@InovioPharma
This week: Simon Best, leading laryngologist & a Principal Investigator in INOVIO’s Phase 1/2 trial w/ INO-3107 will join CEO Jacqui Shea & CMO Mike Sumner for a virtual fireside chat on RRP & INO-3107 as a potential treatment. ir.inovio.com/news-releases/news-releases-details/2024/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO & @Coherus_Bio announce clinical collaboration to advance development of INO-3112 in combination with LOQTORZI™ (toripalimab-tpzi) for patients with locoregionally advanced, high-risk, HPV16/18+ head & neck cancer. Read more here: ir.inovio.com/news-releases/news-releases-details/2024/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
CEO Jacqui Shea on the next steps for INO-3107, a game-changing potential treatment for patients suffering from #rrp. Read more here: ir.inovio.com/news-releases/news-releases-details/2024/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO plans to submit a BLA for INO-3107 in the 2nd half of 2024 and continue commercial preparations for a potential 2025 launch. Read more: ir.inovio.com/news-releases/news-releases-details/2024/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
See you in Santa Clara next week! INOVIO will be at #wvcwest to talk about the full spectrum of our #dnamedicines platform, from early stage dMAb research to the future of cancer vaccines to important progress with our late-stage lead candidate for RRP.
-
INOVIO Pharmaceuticals
@InovioPharma
Chief Commercial Officer Mark Twyman offers insights on INOVIO’s commercial strategy for its lead candidate, INO-3107 for RRP. Listen to more from our Q3 2023 financial results and operational highlights conference call here: app.webinar.net/pgOKRN1x4Vv
-
INOVIO Pharmaceuticals
@InovioPharma
CEO Jacqui Shea on the groundbreaking potential of INO-3107, INOVIO’s lead candidate for #rrp. Listen to more from our Q3 2023 financial results and operational highlights conference call here: app.webinar.net/pgOKRN1x4Vv
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports third quarter 2023 financial results and operational highlights – read more here: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is at #bioeurope this week, the industry's largest gathering of biopharma professionals in Europe. Looking forward to networking and talking about the power and potential of #dnamedicine!
-
INOVIO Pharmaceuticals
@InovioPharma
Looking forward to #wvcwc and this conversation on the future of cancer vaccines.
World Vaccine Congress
@vaccinenation
🗣️ Panel Announcement | Unleashing the Power of Cancer Vaccines: Strategies for the Future
We are excited to announce one of our panels for the upcoming #wvcwc
There’s still time to join us! Register now, tickets starting from $495! www.terrapinn.com/WVCWC/GN
#wvcwc #vaccines -
INOVIO Pharmaceuticals
@InovioPharma
#dnamedicine in the spotlight! Proud of our partners at @PennCancer's Basser Center for BRCA and their important research with one of our DNA vaccine candidates, INO-5401. #breastcancerawareness #powerofpartnerships
BasserBRCA
@BasserBRCA
Inside the latest developments of a vaccine to prevent cancer: Susan Domchek, MD, @basserbrca executive director, speaks with @NBCNews' @annenbcnews for @TODAYshow about the team's revolutionary work on a vaccine to stop cancers caused by #brca mutations www.today.com/video/inside-the-latest-developments-of-a-v…
-
INOVIO Pharmaceuticals
@InovioPharma
We are pleased to announce that INOVIO Chief Scientific Officer Laurent Humeau will be sharing a poster presentation at the International Society for Vaccines Annual Congress in Lausanne, Switzerland on 22-24 October.
-
INOVIO Pharmaceuticals
@InovioPharma
The latest news on INO-3107 offers much-needed hope for patients suffering from #rrp. But it’s just the first step in INOVIO’s mission to deliver on the promise of DNA medicine for patients around the world. See our latest corporate presentation here: ir.inovio.com/events-and-presentations/default.aspx
-
INOVIO Pharmaceuticals
@InovioPharma
📣CMO Michael Sumner will be in Barcelona for #wvceurope on October 18 to talk about #dnamedicine in infectious disease. #wvc2023 #wvc #wvceu
-
INOVIO Pharmaceuticals
@InovioPharma
#rrp is a rare and debilitating disease of the respiratory tract caused by HPV. There are few treatment options beyond repeated surgery, which is the current standard of care. Learn more about RRP and its impact on patients here: rrpf.org/what-is-rrp/
-
INOVIO Pharmaceuticals
@InovioPharma
The latest news on the development of INO-3107 for #rrp offers hope to patients looking for an alternative to disruptive surgery. Read more here: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
More breaking news from INOVIO: Data from our completed Phase 1/2 trial of INO-3107 for #rrp can be used to submit a BLA under the Accelerated Approval program based on FDA feedback. Read the press release here: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Happening today: Don’t miss INOVIO CEO Jacqueline Shea presenting at the H.C. Wainwright 25th Annual Global Investment Conference. Tune in here at 4:30 PM ET: ir.inovio.com/events-and-presentations/default.aspx
-
INOVIO Pharmaceuticals
@InovioPharma
Read more about the benefits of Breakthrough Therapy designation and what it means for the development of INO-3107 and potentially for #rrp patients suffering from this debilitating disease: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
📣Breaking news from INOVIO: the FDA has granted Breakthrough Therapy designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis (#rrp). Read more here: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports second quarter 2023 financial results and operational highlights – read more here: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today is Glioblastoma Awareness Day – let’s help raise awareness about this devastating brain cancer for those living with it and those who will be diagnosed in the future: braintumor.org/gbmday #gbmday
-
INOVIO Pharmaceuticals
@InovioPharma
Glioblastoma is a deadly, hard-to-treat brain cancer. Learn more about recent research showing potential for #dnamedicines to improve on the standard of care and expand treatment options for patients: ir.inovio.com/news-releases/news-releases-details/2022/IN… #gbmday
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO’s Dr. Jeffrey Skolnik was at the @EuropeLaryngSoc Annual Meeting this week sharing positive data from our recently completed Phase 1/2 trial of INO-3107 for #rrp – another important opportunity to talk about the potential of #dnamedicine for RRP patients around the world.
-
INOVIO Pharmaceuticals
@InovioPharma
Join INOVIO at #bio2023, the world's largest biotech gathering in Boston, June 5-8. We’ll be there to meet other innovators, connect with partners & talk about #dnamedicine. Want to meet up? Reach out to our business development team: Business.development@inovio.com
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO’s Elisabeth Gillespie (Manager, Immunology & Biomarkers) joined fellow innovators at #vsboston this week to discuss advancing DNA medicines & recent clinical learnings from our candidates targeting #ebola and #rrp. Learn more about the summit here: www.hugedomains.com/domain_profile.cfm?d=biogatesc.com
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is pleased to be presenting updates on our #dnamedicines pipeline at the @Jefferies Health Care Conference in NYC on June 9. More details here: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
The European Commission has granted orphan drug designation for INO-3107, INOVIO’s product candidate for the treatment of #rrp. Read more here: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Data from the first cohort of our Phase 1/2 trial of INO-3107 for the treatment of RRP has been published online in The Laryngoscope, the leading journal for otolaryngology. Abstract here: onlinelibrary.wiley.com/doi/10.1002/lary.30749 @Triological Society @RRPFORG1
-
INOVIO Pharmaceuticals
@InovioPharma
Proud to announce that Dr. Diana Guimet, INOVIO’s Principal Scientist for Preclinical R&D, has been selected for a poster presentation at @ASGCTherapy’s 26th Annual Meeting. #asgct23
-
INOVIO Pharmaceuticals
@InovioPharma
Congratulations to Cookab Hashemi, one of @washingtonian's 500 Most Influential People shaping policy in DC! We are so grateful to have Cookab on our team, advocating for biotech innovation and #dnamedicine. Read more: www.washingtonian.com/2023/04/27/washington-dcs-500-most-…
-
INOVIO Pharmaceuticals
@InovioPharma
Read more from our Q1 2023 Financial Results and Operational Highlights here: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports first quarter 2023 financial results and operational highlights – read more here: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Lead investigator Dr. Ted Mau shared new data on INO-3107 the @ABEAnow program at @__COSM last week – read more here: ir.inovio.com/news-releases/news-releases-details/2023/Ne…
-
INOVIO Pharmaceuticals
@InovioPharma
Join Lead Investigator Dr. Ted Mau at the @ABEAnow program at @__COSM, where he’s slated to present more insights from our Ph 1/2 Trial with INO-3107 for the treatment of RRP. Read more: ir.inovio.com/news-releases/news-releases-details/2023/IN… #2023cosm
-
INOVIO Pharmaceuticals
@InovioPharma
The European Committee for Orphan Medicinal Products has provided a positive opinion of INOVIO’s application for orphan drug designation for INO-3107, our product candidate for RRP. The EU Commission will make a final decision in May. Read more: ir.inovio.com/news-releases/news-releases-details/2023/Eu…
-
INOVIO Pharmaceuticals
@InovioPharma
We envision a future where the power of #dnamedicine helps protect and save lives across the world. Learn more about our current candidates and research here: inovio.com/dna-medicines-pipeline/ #dnaday23
-
INOVIO Pharmaceuticals
@InovioPharma
70 years after the discovery of the double helix, we're building precisely engineered DNA molecules that teach the body’s cells how to fight disease. On #dnaday23, learn more about how #dnamedicines work & how INOVIO hopes to deliver on their promise: inovio.com/dna-medicines-technology/
-
INOVIO Pharmaceuticals
@InovioPharma
Happy #dnaday23! Let's celebrate the pioneering work of all the scientists who explored & mapped the basic building blocks of life. Their work opened up a world of potential & made the development of #dnamedicines possible.
-
INOVIO Pharmaceuticals
@InovioPharma
Lead investigator Dr. Angela Huttner was at #eccmid2023 presenting the positive Phase 1b results for INO-4201 as an Ebola booster for rVSV-ZEBOV (Ervebo®). Read more: ir.inovio.com/news-releases/news-releases-details/2023/Da…
-
INOVIO Pharmaceuticals
@InovioPharma
Join lead investigator Dr. Angela Huttner at #eccmid2023 for an oral presentation on the positive Phase 1b results for INO-4201 as an Ebola booster for rVSV-ZEBOV (Ervebo®). Read more: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
CMO Michael Sumner was on deck today at #wvcusa to present learnings from recent research on our #dnamedicine candidates targeting Ebola and Recurrent Respiratory Papillomatosis (RRP) #wvc2023
-
INOVIO Pharmaceuticals
@InovioPharma
Don’t miss CMO Michael Sumner at #wvcusa next week - he’ll be presenting learnings from recent research on our #dnamedicine candidates targeting Ebola and Recurrent Respiratory Papillomatosis (RRP).
-
INOVIO Pharmaceuticals
@InovioPharma
👋Meet Dr. Cheryl Elder, our new SVP of Regulatory Affairs. Bringing decades of experience in global drug development & regulatory strategies, we're delighted to welcome Cheryl to the talented team at INOVIO. Look for her bio on the Leadership page at inovio.com
-
INOVIO Pharmaceuticals
@InovioPharma
Dr. Jeffrey Skolnik is at the @GbmSummit today to discuss new solutions in the field of GBM therapy and share learnings on how DNA medicines could play a role. Learn more about INOVIO’s GBM work here: ir.inovio.com/news-releases/news-releases-details/2022/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Happening today! President & CEO Jacqui Shea at the @Oppenheimer 33rd Annual Healthcare Conference – tune in here for the webcast, replays available for the next 90 days: ir.inovio.com/events-and-presentations/default.aspx
-
INOVIO Pharmaceuticals
@InovioPharma
President & CEO Jacqui Shea will present at the @Oppenheimer 33rd Annual Healthcare Conference on March 13. Tune in to the webcast of the presentation on the INOVIO Investor Relations Events page: ir.inovio.com/events-and-presentations/default.aspx
-
INOVIO Pharmaceuticals
@InovioPharma
More than 42 million Americans are currently infected with types of human papilloma virus that cause disease. Most HPVs are harmless, but others can cause warts, some kinds of cancer, or even a rare disease called Recurrent Respiratory Papillomatosis. #hpvawareness
-
INOVIO Pharmaceuticals
@InovioPharma
Today is International #hpv Awareness Day – so let’s start with the basics.
-
INOVIO Pharmaceuticals
@InovioPharma
That’s a wrap on #rarediseaseweek! We joined multiple events focused on patients & the power of innovation. Special thanks to all the congressional staff who took time to learn about the potential we see for DNA medicines in rare diseases #rddnih #fdararediseaseday #raredc2023
-
INOVIO Pharmaceuticals
@InovioPharma
Read more from our Q4 and Full Year 2022 Financial Results and Clinical Highlights here: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports fourth quarter and full year 2022 financial results and clinical highlights – read more here: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Recurrent Respiratory Papillomatosis is a debilitating disease with no cure. Many patients face a lifetime of surgeries. This #rarediseaseday, INOVIO stands committed to delivering on the promise of DNA medicines for RRP patients & their families.
-
INOVIO Pharmaceuticals
@InovioPharma
Dr. Jeffrey Skolnik on candidate INO-3107’s potential impact on patients. Read more: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO Announces Positive Preliminary Results from Second Cohort of Phase 1/2 Trial with INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis – Read more here: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced positive Phase 1b results for INO-4201 as an #ebola booster for rVSV-ZEBOV (Ervebo®). Read more: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced a strategic reorganization and updates on our continued efforts to focus on promising DNA medicine candidates. Read more: ir.inovio.com/news-releases/news-releases-details/2023/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we provided an update on our Lassa Fever and MERS programs. Read more: ir.inovio.com/news-releases/news-releases-details/2022/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced INOVIO’s third quarter 2022 financial results. Read more: ir.inovio.com/news-releases/news-releases-details/2022/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we provided an update on INO-4800, our COVID-19 heterologous booster vaccine candidate. Read more: ir.inovio.com/news-releases/news-releases-details/2022/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced positive interim Phase 1/2 results for INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP). #hpv #rrp #dnamedicines Read more: ir.inovio.com/news-releases/news-releases-details/2022/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced INOVIO’s second quarter 2022 financial results and program developments. Read more: ir.inovio.com/news-releases/news-releases-details/2022/IN…
-
INOVIO Pharmaceuticals reposted
The Wistar Institute
@TheWistar
First-in-human clinical trials begin for a #covid19 #dmab candidate by @TheWistar's pioneering immunologist Dr. David Weiner and collaborators. Read more: www.wistar.org/news/press-releases/collaboration-advances… @DARPA @JPEOCBRND @InovioPharma @AstraZeneca @PennMedicine @IndianaUniv
-
INOVIO Pharmaceuticals
@InovioPharma
We are pleased to announce the appointment of Dr. Michael Sumner, MB BS, MBA, as Chief Medical Officer of INOVIO. Read more: ir.inovio.com/news-releases/news-releases-details/2022/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
It was a pleasure to join fellow industry leaders at #asco2022! #inovio was able to present new data findings for patients who are newly diagnosed with #gbm. ir.inovio.com/news-releases/news-releases-details/2022/IN…
-
INOVIO Pharmaceuticals reposted
Dana-Farber News
@DanaFarberNews
#glioblastoma study shows combination immunotherapy is safe and early data on effectiveness is encouraging. Dana-Farber's David Reardon, MD, details more at #asco22 about the combination of a potent vaccine platform with immune checkpoint blockade
➡️ meetings.asco.org/2022-asco-annual-meeting/14350?presenta… -
INOVIO Pharmaceuticals
@InovioPharma
INOVIO Announces Survival Results for INO-5401 + INO-9012 in Combination with Libtayo® (cemiplimab) in Patients with Newly Diagnosed GBM at ASCO Annual Meeting 2022.
Read more here: ir.inovio.com/news-releases/news-releases-details/2022/IN… -
INOVIO Pharmaceuticals
@InovioPharma
Today we recognize #dayofgrey & #braintumorawarenessmonth with facts on Glioblastoma Multiforme (GBM), an aggressive brain tumor. GBM is the most common malignant brain/CNS tumor accounting for 47.7% of all cases. Read more on our immuno-oncology programs: inovio.com/our-focus-serving-patients/immuno-oncology/
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced the appointment of Jacqueline Shea, Ph.D., as President and Chief Executive Officer of INOVIO, effective immediately. Dr. Shea succeeds Dr. J. Joseph Kim in these roles. Read more details on Dr. Shea’s appointment here: ir.inovio.com/news-releases/news-releases-details/2022/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced INOVIO’s first quarter 2022 financial results and program developments. Read more: ir.inovio.com/news-releases/news-releases-details/2022/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we join the NHGRI to celebrate #nationaldnaday. We recognize all the innovation in DNA technology and remain committed to rapidly bringing to market precisely designed and delivered DNA medicines. Learn more about our DNA technology on our website: www.inovio.com/dna-medicines-technology/
-
INOVIO Pharmaceuticals
@InovioPharma
Vaccination is one way to potentially prevent #hpv and HPV-associated diseases, such as cervical #hsil. Despite the availability of HPV vaccines in the U.S., cervical HSIL continues to be a public health issue.
Learn more about cervical HSIL: inovio.com/our-focus-serving-patients/hpv-associated-dise… -
INOVIO Pharmaceuticals
@InovioPharma
Today, on #worldhealthday2022, we join the @WHO and other global health organizations in recognizing the importance of technology, innovation, and stewardship in creating a #healthiertomorrow.
-
INOVIO Pharmaceuticals
@InovioPharma
Although the HPV vaccine was introduced in the U.S. over 15 years ago, a significant portion of people who are still unvaccinated may remain vulnerable to developing #hpv-related diseases, including cervical #hsil.
Learn more about cervical HSIL: inovio.com/our-focus-serving-patients/hpv-associated-dise… -
INOVIO Pharmaceuticals
@InovioPharma
March 4th is International #hpvawarenessday. INOVIO reaffirms its commitment to the fight against HPV and HPV-related diseases and cancers. @IPVSociety #askabouthpv inovio.com/our-focus-serving-patients/hpv-associated-dise…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced INOVIO’s fourth quarter 2021 financial results. Read more: ir.inovio.com/news-releases/news-releases-details/2022/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO will host a live conference call and webcast at 4:30 PM ET today to share our fourth quarter 2021 financial results. Make sure to tune in here: ir.inovio.com/events-and-presentations/event-details/2022…
-
INOVIO Pharmaceuticals
@InovioPharma
Join INOVIO in taking an active role in the fight against cancer this #worldcancerday. Learn more about our clinical trials for #dnamedicines aimed at preventing and treating specific cancers: inovio.com/our-focus-serving-patients/immuno-oncology/ #wcd2022
-
INOVIO Pharmaceuticals
@InovioPharma
In the U.S., squamous cell anal cancer incidence rose 2.7% per year between 2001 and 2015. Learn about opportunities to improve screening for anal precancers and cancers identified in this @SWHR working group: journals.sagepub.com/doi/10.1089/jwh.2021.0507?cf-mal-red… #swhrtalkshpv
-
INOVIO Pharmaceuticals
@InovioPharma
Learn more about the gaps and opportunities identified to improve prevention and treatment of HPV-related precancers and cancers, including cervical, by a @SWHR working group: journals.sagepub.com/doi/10.1089/jwh.2021.0507?cf-mal-red… #swhrtalkshpv #cervicalcancer
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced full enrollment in REVEAL2, our second global Phase 3 clinical trial for VGX-3100, our candidate to treat HPV 16/18 related cervical HSIL. More updates and data are available here: ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
We are excited to announce full enrollment of the booster trial for INOVIO's #ebola vaccine candidate, INO-4201, in collaboration with GuardRX and Geneva University Hospitals.
-
INOVIO Pharmaceuticals reposted
SWHR
@SWHR
Just published! Read SWHR's paper in the Journal of Women’s Health @LiebertPub about the gaps and opportunities to improve health outcomes for #women with HPV-related anogenital #cancers: swhr.org/swhr_resource/gaps-and-opportunities-to-improve-… #swhrtalkshpv
-
INOVIO Pharmaceuticals
@InovioPharma
#dnamedicines are composed of optimized DNA plasmids - small circles of double-stranded DNA - that are synthesized and designed to instruct the body to produce a specific response. Learn more: inovio.com/technology/about-dna-medicine/
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is rapidly moving to evaluate the effectiveness of its #covid19 vaccine candidates - INO-4800 and INO-4802 - against the new Omicron variant. Learn more: ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
#dnamedicines are an “off-the-shelf” product – they are stable at room temperature and do not need to be frozen during transport or storage. Learn more: inovio.com/technology/about-dna-medicine/
-
INOVIO Pharmaceuticals
@InovioPharma
Join INOVIO at the @IPVSociety’s International Papillomavirus Conference (IPVC), where we will share our Phase 2 data for VGX-3100, an investigational non-surgical treatment for anal HSIL. Learn more at #ipvc2021 and read more here: inovio.com/our-focus-serving-patients/hpv-associated-dise…
-
INOVIO Pharmaceuticals
@InovioPharma
Join INOVIO at the @IPVSociety’s International Papillomavirus Conference (IPVC), where we will share our Phase 2 data for VGX-3100, an investigational non-surgical treatment for vulvar HSIL.
Learn more at #ipvc2021 and read more here: inovio.com/our-focus-serving-patients/hpv-associated-dise… -
INOVIO Pharmaceuticals
@InovioPharma
Join INOVIO at the @IPVSociety’s International Papillomavirus Conference, where we will share Phase 3 REVEAL 1 data for VGX-3100, an investigational non-surgical treatment for cervical HSIL.
Learn more at #ipvc2021 and read more here: inovio.com/our-focus-serving-patients/hpv-associated-dise… -
INOVIO Pharmaceuticals
@InovioPharma
Today we announced INOVIO’s collaboration with GuardRX and the Geneva University Hospitals for booster dosing of INO-4201, our #ebola vaccine candidate. We stand committed to supporting global infectious disease health measures. Learn more: ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is looking forward to participating in @IPVSociety’s 2021 International Papillomavirus Conference (IPVC). We’re giving eight presentations this week.
Learn more about our presence at #ipvc2021 here: ir.inovio.com/news-releases/news-releases-details/2021/IN… -
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is excited to have presented at the #sitc2021 pre-conference. Our study showed that INO-5401+INO-9012 with cemiplimab and radiation/TMZ have an acceptable safety profile, are immunogenic, and may improve survival in newly diagnosed GBM. #dnamedicine
-
INOVIO Pharmaceuticals
@InovioPharma
We are excited to be participating in the SITC 2021 pre-conference workshop, and look forward to Dr. Reardon’s presentation: “INO-5401 and INO-9012 Delivered Intramuscularly (IM) with Electroporation (EP) in Combination with Cemiplimab (REGN2810) in Newly Diagnosed Glioblastoma."
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced INOVIO’s third quarter 2021 financial results. View the full press release: ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO will host a live conference call and webcast at 4:30 PM ET to share our third quarter 2021 financial results. Tune in here: ir.inovio.com/events-and-presentations/event-details/2021…
-
INOVIO Pharmaceuticals
@InovioPharma
The @US_FDA has lifted its partial clinical hold following review of additional non-clinical, clinical, and device information provided by INOVIO for our #covid19 vaccine candidate, INO-4800. Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
We are pleased to share that the Thai Food and Drug Administration has authorized the start of the INNOVATE Phase 3 segment for #covid19 vaccine candidate, INO-4800, adding Thailand to the growing list of countries who have authorized INOVIO’s efficacy evaluation of INO-4800.
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO will participate in the following virtual investor conferences:
Stifel 2021 Virtual Healthcare Conference
Monday, November 15, 2021
10:40 AM ET
Fireside Chat
Jefferies London Healthcare Conference
Thursday, November 18, 2021
3:00 AM ET
Fireside Chat
INOVIO Pharmaceuticals
@InovioPharma
Piper Sandler 33rd Annual Virtual Healthcare Conference
Monday, November 22, 2021
10:00 AM ET
Fireside Chat
The virtual presentations will be available through the INOVIO Investor Relations Events page. All presentation times are subject to change. -
INOVIO Pharmaceuticals
@InovioPharma
We are pleased to share that the @CDSCO_INDIA_INF has authorized the start of our global Phase 3 trial for INO-4800 in India, marking the fifth country to participate in this trial following allowances from Brazil, the Philippines, Mexico and Colombia. ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced the preprint publication in @biorxivpreprint of our NHP study illustrating the durability of immunity following vaccination with INO-4800 and the use of either INO-4800 or INO-4802 in prime-boost regimens. #covid19 Link: www.biorxiv.org/content/10.1101/2021.10.27.466163v1
-
INOVIO Pharmaceuticals reposted
CEPI
@CEPIvaccines
"I am delighted to see the rapid progress in enrollment for this pivotal trial to assess the safety and immunogenicity of @InovioPharma's promising Lassa vaccine candidate in Ghana."
- 💬 Dr Melanie Saville, Director of Vaccine R&D at CEPI 🌍 (1/3)
INOVIO Pharmaceuticals
@InovioPharma
We’ve reached full enrollment of our clinical trial for INOVIO's #lassafever vaccine candidate, INO-4500, marking an important milestone. This is the first Lassa virus vaccine trial to be carried out in Africa, launched in partnership with @CEPIvaccines. ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
We’ve reached full enrollment of our clinical trial for INOVIO's #lassafever vaccine candidate, INO-4500, marking an important milestone. This is the first Lassa virus vaccine trial to be carried out in Africa, launched in partnership with @CEPIvaccines. ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals reposted
Iván Duque 🇨🇴
@IvanDuque
En nuestro propósito de avanzar en el desarrollo y producción de vacunas en Colombia, no solo para covid-19 sino para otras patologías, asistimos a la firma del memorando de entendimiento con @InovioPharma, acuerdo que se consolida luego de nuestra visita a Estados Unidos.
This media couldn't be displayed. See it on the original post. -
INOVIO Pharmaceuticals
@InovioPharma
How are #dnamedicines administered? Our proprietary smart devices deliver optimized plasmids directly into cells and reversibly open small pores in the cell allowing plasmids to enter, overcoming a limitation of other approaches such as #mrna. Learn more: inovio.com/technology/about-dna-medicine/
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is pleased to share that we have signed a Memorandum of Understanding with Colombia to collaborate on health preparedness initiatives and protection against #covid19. Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Our paper “INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants” was published in npj Vaccines. @Nature_NPJ Link: www.nature.com/articles/s41541-021-00384-7
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is grateful for the support of Mexican Foreign Secretary @m_ebrard and his team at SRE. INOVIO looks forward to building a partnership with Mexico to support the health of the Mexican people as we begin P3 trial of #covid19 vaccine INO-4800 in Mexico in the coming weeks.
INOVIO Pharmaceuticals
@InovioPharma
INOVIO agradece el apoyo del Canciller mexicano @m_ebrard y su equipo en la SRE. INOVIO espera construir una sociedad con México para apoyar la salud del pueblo mexicano mientras comenzamos la prueba P3 de la vacuna #covid19 INO-4800 en México en las próximas semanas.
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is proud to continue supporting the worldwide #covid19 response and grateful to the multiple health authorities and global leaders like @invimacolombia who have granted approval for our global Phase 3 trial for INO-4800.
Iván Duque 🇨🇴
@IvanDuque
Nos reunimos con Joseph Kim, CEO de @InovioPharma, farmacéutica que el @invimacolombia autorizó para realizar ensayo clínico de la fase 3 de vacunas contra Covid en Colombia. Exploramos la firma de memorando de entendimiento para desarrollo y producción de biológicos en el país.
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced the preprint publication in @medrxivpreprint of our Phase 1 clinical data on homologous boosting of our #covid19 DNA vaccine candidate, INO-4800. ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
We are pleased to share that @invimacolombia has authorized the start of our global Phase 3 trial for INO-4800. This approval marks the fourth country to engage in this #covid19 vaccine trial, following allowances from Brazil, the Philippines and Mexico. ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals reposted
CBS 8 San Diego
@CBS8
San Diego pharmaceutical company beginning third phase of trials for new COVID-19 vaccine www.cbs8.com/mobile/article/news/health/coronavirus/vacci…
-
INOVIO Pharmaceuticals
@InovioPharma
With no treatment to address both cervical dysplasia and the underlying #hpv infection, invasive surgery - with the risk of recurrence - has been the only option. INOVIO’s leading candidate, VGX-3100, offers a new solution for patients: inovio.com/our-focus-serving-patients/hpv-associated-dise…
-
INOVIO Pharmaceuticals
@InovioPharma
Approximately 7 million #hpv infections occur each year with high-risk HPV genotypes 16/18, which can lead to cancer. For more information, visit: inovio.com/our-focus-serving-patients/hpv-associated-dise…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is proud to participate in @IDWeek2021 with the presentation of three posters about our approach of developing DNA vaccines to combat the ongoing #covid19 pandemic. Register and see more at www.idweek.org!
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is committed to helping fight the pandemic and supporting global health security with our #covid19 vaccine candidate. We strongly support the collective efforts of @POTUS #covid19summit and all those working to increase global vaccine access. Because the world can’t wait.
-
INOVIO Pharmaceuticals
@InovioPharma
.@COFEPRIS has authorized the start of INOVIO’s global Phase 3 trial in Mexico for INO-4800, INOVIO’s #covid19 DNA vaccine. This is the third country vaccine trial approval for INOVIO’s Phase 3 trial; previous allowances from Brazil and the Philippines. ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
The @FDAPhilippines has authorized the start of our global Phase 3 trial in the Philippines for INO-4800. With many countries experiencing low vaccination rates and an increase in infections, INOVIO is committed to supporting the worldwide #covid19 response.
-
INOVIO Pharmaceuticals
@InovioPharma
There is an urgent need for an effective, tolerable and non-invasive treatment for Recurrent Respiratory Papillomatosis to eliminate the need for recurrent surgeries. INOVIO’s #dnamedicine candidate, INO-3107, is a potential non-surgical option: inovio.com/our-focus-serving-patients/hpv-associated-dise…
-
INOVIO Pharmaceuticals
@InovioPharma
Congratulations to our SVP of Research and Development, Dr. Kate Broderick, for being recognized as one of @SDbusiness' most Influential Women in Life Sciences! Learn more about the award here: www.sdbj.com/news/2021/aug/27/women-influence-life-scienc…
San Diego Business Journal
@SDbusiness
Congratulations to SDBJ's 2021 Women of Influence in Life Sciences!
Click Here to see the full Special Section: sdbj.clickthiscard.top/wzjfph
#sdbj #womenofinfluence #lifesciences -
INOVIO Pharmaceuticals
@InovioPharma
Today we announced that we have received regulatory authorization from @anvisa_oficial in Brazil to initiate our global Phase 3 trial for INO-4800, our #dnavaccine candidate for #covid19 developed in partnership with Advaccine. Learn more: ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today INOVIO announced our second quarter 2021 financial results and mid-year updates. View the full press release: ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced that INOVIO and Advaccine received regulatory allowance for two heterologous prime-boost clinical trials in China using INO-4800, INOVIO's #covid19 DNA vaccine candidate.
Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN… -
INOVIO Pharmaceuticals
@InovioPharma
INOVIO will release second quarter 2021 financial results after market close today, followed by a live conference call and webcast at 4:30pm ET to deliver mid-year updates on our #dnamedicines platform. Join here: ir.inovio.com/events-and-presentations/event-details/2021…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced the first participant dosed in our Phase 2 trial for INOVIO’s #dnavaccine against Middle East Respiratory Syndrome (MERS).
Learn more about the study and our vaccine here: www.prnewswire.com/news-releases/inovio-doses-first-parti… -
INOVIO Pharmaceuticals reposted
CEPI
@CEPIvaccines
📢The largest ever study created by CEPI to provide an accurate assessment on Lassa fever infections has expanded to more countries in West Africa🌍
Lassa fever is a potentially fatal haemorrhagic illness which can cause headache, fever, and bleeding.
cepi.net/news_cepi/largest-ever-lassa-fever-study-expands… -
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is proud to partner with @CEPIvaccines in the advancement of our #lassavaccine candidate, INO-4500. This newly expanded first in Africa research study is an important step in the fight against #lassafever in West Africa. Read more: cepi.net/news_cepi/largest-ever-lassa-fever-study-expands…
-
INOVIO Pharmaceuticals
@InovioPharma
We are excited to announce the expansion of our partnership with Advaccine Biopharmaceuticals Suzhou Co., Ltd. to jointly conduct a global Phase 3 segment of the ongoing Phase 2/3 trial of our #covid19 vaccine candidate INO-4800! Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN… #dnamedicine
-
INOVIO Pharmaceuticals
@InovioPharma
We are thrilled to be presenting at this year’s virtual #eurogin2021! We look forward to showcasing research demonstrating our commitment to patients with #hpv and HPV-related diseases and pre-cancers. Find out more: inovio.com/our-focus-serving-patients/hpv-associated-dise… @EUROGINHPV #dnamedicine
-
INOVIO Pharmaceuticals
@InovioPharma
In recognition of National #dayofgray and #braintumorawarenessmonth, we’re sharing some key facts about Glioblastoma Multiforme (GBM), the most aggressive and most frequently occurring type of brain cancer. Read more about our immuno-oncology programs: inovio.com/our-focus-serving-patients/immuno-oncology/
INOVIO Pharmaceuticals
@InovioPharma
While there have been a limited number of new GBM therapies approved over the last 10 years, disease prognosis remains extremely poor.
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced the appointment of Roger D. Dansey, M.D. to our Board of Directors. Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN… #dnamedicine
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO's Pan-COVID-19 vaccine candidate INO-4802 induced potent neutralizing antibodies and T cell responses against the original Wuhan strain as well as against B.1.1.7 (UK variant), B.1.351 (South African variant) and P.1. (Brazilian variant) in preclinical models.
INOVIO Pharmaceuticals
@InovioPharma
Link to paper: www.biorxiv.org/content/10.1101/2021.05.11.443592v1.artic… Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN… #dnamedicine #covid19
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced 1Q 2021 financial results. View the full presentation and highlights: ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced positive safety, tolerability, and immunogenicity data from the Phase 2 segment of our Phase 2/3 clinical trial in the U.S. evaluating INO-4800, our DNA vaccine candidate for #covid19. Link to paper: www.medrxiv.org/content/10.1101/2021.05.07.21256652v1 Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we will host a live conference call and webcast at 4:30 p.m. ET to discuss INOVIO’s first quarter 2021 financial results and provide a general business update regarding our DNA Medicines Platform. Join here: ir.inovio.com/events-and-presentations/event-details/2021…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced that we are adjusting INO-4800 clinical development strategy to focus on global unmet #covid19 vaccine needs. We are planning for a predominantly ex-U.S. Phase 3 trial for COVID-19 vaccine candidate, INO-4800. Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced the results of a study focusing on the human immune responses induced by our DNA vaccine candidate for COVID-19, INO-4800, against variants of concern. #covid19 #dnamedicine Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced the appointment of Michael Cordera as Executive Vice President and General Counsel. Mr. Cordera will serve on the company's executive leadership team and will be responsible for the company's legal team and strategy. Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN… #inovio
-
INOVIO Pharmaceuticals
@InovioPharma
Today is International HPV Awareness Day.
HPV affects us all and it takes all of us to beat it. INOVIO remains committed to the ongoing fight against HPV and HPV-related diseases and cancers.
@AskAboutHPV #askabouthpv #dnamedicine -
INOVIO Pharmaceuticals
@InovioPharma
INOVIO to present at upcoming investor conferences in March. #dnamedicine Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced 4Q 2020 financial results. Please tune in to our live webcast to hear more: www.webcaster4.com/Webcast/Page/2021/40128 Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced that we met primary and secondary endpoints among all evaluable subjects for the REVEAL 1 Phase 3 trial, evaluating the safety, tolerability and efficacy of VGX-3100 to treat #hpv-16/18-associated cervical HSIL. Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN… #dnamedicine
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced an extension of our partnership with @QIAGEN to develop liquid biopsy-based companion diagnostic products based on next-generation sequencing (NGS) technology to complement INOVIO's therapies. Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN… #dnamedicine #hpv
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced the first participant was dosed in a Phase 1B clinical trial for INO-4500, our DNA vaccine candidate for #lassa fever, in Ghana. INO-4500 is the first vaccine candidate for Lassa fever to enter human trials. Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN… #dnamedicine
-
INOVIO Pharmaceuticals
@InovioPharma
In honor of #worldcancerday, we want to recognize all the patients in our clinical trials for #dnamedicine programs aimed at treating specific cancers like #gbm. Thank you for your participation and for taking an active role in the fight against cancer. #endgbm #wcd2021
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO today announced the pricing of an underwritten public offering of 17,700,000 shares of its common stock at a public offering price of $8.50 per share. Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN… #dnamedicine
-
INOVIO Pharmaceuticals
@InovioPharma
Today INOVIO announced that it has commenced an underwritten public offering of $150 million of shares of its common stock. Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN… #dnamedicine
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced positive efficacy results for our open-label Phase 2 trial of VGX-3100 to treat HPV-16 and HPV-18-associated vulvar dysplasia. Based upon these results INOVIO is planning to pursue Phase 3 development. Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN… #dnamedicine #hpv
-
INOVIO Pharmaceuticals
@InovioPharma
Inspirational Women in STEM and Tech: Dr Kate E Broderick of ‘INOVIO’ On The 5 Leadership Lessons by Penny Bauder link.medium.com/XFtd3wVvJcb #inovio #dnamedicine
-
INOVIO Pharmaceuticals
@InovioPharma
We have entered into a collaboration and license agreement giving Advaccine Biopharmaceuticals the exclusive right to develop, manufacture, and commercialize #covid19 DNA vaccine candidate INO-4800 within Greater China. Read more: ir.inovio.com/news-releases/news-releases-details/2021/IN… #dnamedicine
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced the publication of peer-reviewed Phase 1 clinical data from the first cohort of 40 participants for our COVID-19 DNA vaccine candidate, INO-4800, in EClinicalMedicine. Link: www.sciencedirect.com/science/article/pii/S2589537020304338 Read more: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnamedicine #covid19
-
INOVIO Pharmaceuticals reposted
FOX4 News Kansas City
@fox4kc
With Pfizer and Moderna making headlines, learn about vaccine ‘cousin’ undergoing clinical trial in metro fox4kc.com/news/with-pfizer-and-moderna-making-headlines-… via @ReganPorterTV
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO's Phase 2 vaccine clinical trials underway www.10news.com/news/local-news/inovios-phase-2-vaccine-cl… #covid19 #dnamedicine
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO, @TheWistar, @AstraZeneca, @Penn, and @IndianaUniv received a $37.6M grant from @DARPA to use INOVIO's dMAb® technology to develop anti-SARS-CoV-2-specific dMAbs. Read more: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnamedicine #covid19
-
INOVIO Pharmaceuticals
@InovioPharma
Clinical data was published in Vaccines by MDPI which demonstrated that PENNVAX-GP, INOVIO's DNA vaccine against HIV-1, was safe, tolerable, and acceptable in healthy adults. Abstract: www.mdpi.com/2076-393X/8/4/741 #dnamedicine #hiv
-
INOVIO Pharmaceuticals
@InovioPharma
We are proud to announce the dosing of the first subject in our Phase 2 clinical trial for #covid19 DNA vaccine candidate INO-4800 in China. Advaccine is conducting and funding the P2 trial in China, which is expected to fully enroll by the end of this month.
INOVIO Pharmaceuticals
@InovioPharma
Read more: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnamedicine #coronavirus
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced positive Phase 2 efficacy results demonstrating that VGX-3100 showed resolution of HPV-16/18-associated precancerous anal lesions (HSIL) in 50% (11 of 22) of subjects six months following the start of treatment. Read more: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnamedicine
-
INOVIO Pharmaceuticals
@InovioPharma
We are proud to announce that we have dosed the first subject in the Phase 2 segment of our Phase 2/3 clinical trial INNOVATE evaluating DNA medicine INO-4800, our COVID-19 vaccine candidate. Read more: ir.inovio.com/news-releases/news-releases-details/2020/IN… #covid19 #dnamedicine
-
INOVIO Pharmaceuticals
@InovioPharma
We are excited to announce an agreement with @Eurogentec to manufacture INOVIO's COVID-19 vaccine candidate INO-4800 at their industry-leading GMP plasmid production scales. Read more: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnamedicine #covid19 #coronavirus #vaccine
-
INOVIO Pharmaceuticals
@InovioPharma
Clinical data from our novel combination trial of #dnamedicines INO-5401 and INO-9012 in combination with PD-1 inhibitor Libtayo® in the treatment of newly diagnosed #gbm will be presented by Dr. David Reardon at the SNO 2020 Annual Meeting. Read more: ir.inovio.com/news-releases/news-releases-details/2020/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Human Vaccines & Immunotherapeutics recently published durability data on our investigational DNA-based immunotherapy as an alternative to surgery and ablation for #hpv 16/18 positive cervical High-Grade Squamous Intraepithelial Lesion (HSIL) #dnamedicine www.tandfonline.com/doi/full/10.1080/21645515.2020.1823778
-
INOVIO Pharmaceuticals
@InovioPharma
Tune in to the Stifel 2020 Virtual Healthcare Conference for the fireside chat with INOVIO President & CEO Dr. J. Joseph Kim and Stifel analyst Stephen Willey. Link: wsw.com/webcast/stifel27/ino/1923040
-
INOVIO Pharmaceuticals
@InovioPharma
We are excited to announce the initiation of the Phase 2 segment of our Phase 2/3 clinical trial for our #covid19 DNA vaccine candidate, INO-4800. The Phase 2/3 trial will be funded by the U.S. Department of Defense. #dnavaccines Read more: ir.inovio.com/news-releases/news-releases-details/2020/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we reported third quarter 2020 financial results. Tune into our live conference call at 4:30 pm ET for updates on INOVIO's DNA Medicine platform and clinical programs. Read more: ir.inovio.com/news-releases/news-releases-details/2020/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
We are proud to announce the publication in npj Vaccines of a pre-clinical ferret study that found no evidence the G-strain mutation of SARS-CoV-2 would adversely impact the efficacy of #covid19 vaccine candidate INO-4800. #dnamedicine #dnavaccine
CSIRO
@CSIRO
Many COVID-19 vaccines in development were created with the original ‘D-strain’ of the SARS-CoV-2 virus. The dominant strain is now the ‘G-strain.’ But our newly published research found these vaccines should still work against it.
#covid19 #coronavirus www.csiro.au/en/News/News-releases/2020/Potential-covid-1… -
INOVIO Pharmaceuticals
@InovioPharma
We are honored to accept the "Best Therapeutic Vaccine Award" from the 13th Annual Vaccine Industry Excellence Awards for our HPV DNA medicine VGX-3100 targeting HPV-caused pre-cancers! #dnamedicine #hpv #vieawards #worldvaccinecongress
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO reports FDA partial clinical hold for planned Phase 2/3 Trial of COVID-19 vaccine candidate INO-4800. Read more: ir.inovio.com/news-releases/news-releases-details/2020/IN…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is excited to be part of the #esmo2020 Congress with interim combo Phase 2 data in HPV-associated HNSCC. See more: s3.eu-central-1.amazonaws.com/m-anage.com.storage.esmo/st… #dnamedicine #hpv #cancer @myESMO
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is excited to have @ThermoFisher join our Manufacturing Consortium for our #covid19 #dnavaccine candidate, INO-4800. Read more here: ir.inovio.com/news-releases/news-releases-details/2020/IN…
INOVIO Pharmaceuticals
@InovioPharma
Thermo Fisher's own plasmid manufacturing process will be used to produce INO-4800. Our goal is to manufacture 1 million doses of INO-4800 in 2020 and 100 million doses in 2021. #dnavaccine #covid19
-
INOVIO Pharmaceuticals
@InovioPharma
Robb lives with Recurrent Respiratory Papillomatosis (#rrp), a rare, debilitating, & potentially life-threatening disease caused by #hpv genotypes 6/11. RRP is currently incurable but we're on a mission to use #dnamedicines to provide treatment options. youtu.be/o7OdZsKy1fI
-
INOVIO Pharmaceuticals
@InovioPharma
August is National Immunization Awareness Month & an important reminder of the significant advancements we’ve seen in vaccination development because of #covid19. Learn more about our COVID-19 DNA vaccine candidate: inovio.com/our-focus-serving-patients/covid-19/ #dnavaccines #dnamedicines #vax2protect
-
INOVIO Pharmaceuticals
@InovioPharma
Approximately 7 million #hpv infections occur each year with high-risk HPV genotypes 16/18, which can lead to cancer. INOVIO’s #dnamedicines are delivered directly into cells so that the body fights disease from within by producing a natural immune to fight back. #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
Over the next few days, the @WHO is meeting to discuss the adoption of #dnavaccines guidelines to assure the quality, safety and efficacy of DNA vaccine candidates. This is an important step forward in powering a new decade of #dnamedicines. Learn more: www.who.int/biologicals/DNA_vaccines_R_WHO.BS.2020.2380_1…
-
INOVIO Pharmaceuticals
@InovioPharma
In this @HPV_World article, Dr. Prakash K. Bhuyan, INOVIO VP of Clinical Development, HPV Therapeutics, discusses why INOVIO’s #dnaimmunotherapies may help fill a critical gap in the treatment of vulvar HSIL, an #hpv-related disease: www.hpvworld.com/articles/immunotherapy-the-missing-piece… #dnamedicines
-
INOVIO Pharmaceuticals
@InovioPharma
INO-4800’s animal challenge data shows vaccine-induced responses driving immunity against the G614 variant of #covid19, which has emerged with greater infectivity & accounts for >80% of newly circulating virus cases. Learn more: www.cell.com/cell/pdf/S0092-8674(20)30817-5.pdf #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
Animal challenge trials are currently the closest test of efficacy against live virus for #covid19. #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
#dyk: new research highlights the role of #tcell responses in developing an effective #covid19 vaccine? Read why here: www.cell.com/cell/pdf/S0092-8674(20)30610-3.pdf #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO recently announced our DNA vaccine demonstrated long-term protection in non-human primates challenged with SARS-CoV-2, the virus that causes #covid19, 13 weeks after the last vaccination. Read more: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
In Q2, INOVIO has made great strides in developing a #covid19 vaccine candidate. Join us in thanking Dr. Kate Broderick, INOVIO SVP and R&D Lead, and our entire team for their tireless and extraordinary efforts to combat this pandemic. #dnavaccines #dnamedicines
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is the leader in demonstrating how #dnamedicines can be rapidly developed and delivered to produce safe and robust immune responses. We’re proud to be working with a great team developing DNA medicines to meet urgent public health needs. #dnavaccines #dnaimmunotherapies
-
INOVIO Pharmaceuticals
@InovioPharma
Today INOVIO announced second quarter 2020 financial results and mid-year updates for our #dnamedicines, #dnavaccines and #dnaimmunotherapies. We’re excited to share milestones here: ir.inovio.com/news-releases/news-releases-details/2020/IN… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
Dr. Kate Broderick, INOVIO SVP and R&D Lead, was interviewed on @FoxNews about INOVIO’s #covid19 DNA vaccine candidate’s recent animal challenge study results and why they’re promising to her as a scientist and mom. Watch here: youtu.be/3DXfO_3m8yk #dnavaccines #dnamedicines
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO’s #covid19 DNA vaccine candidate, part of the Operation Warp Speed program, showed positive results in a non-human study 13 weeks after the last vaccination. Read more in @Reuters: www.reuters.com/article/us-health-coronavirus-inovio-phar… #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
In this @6abc interview, Dr. Kate Broderick, INOVIO SVP and R&D Lead, discusses the role activating T cells could have in a #covid19 vaccine. One key feature of INOVIO's DNA vaccines is the ability to generate balanced antibody & T cell immune responses #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
Results from an animal challenge of INOVIO’s #covid19 DNA vaccine candidate were published in the non-peer reviewed online preprint site @biorxivpreprint & have been submitted to a peer-reviewed medical journal. See manuscript: www.biorxiv.org/content/10.1101/2020.07.28.225649v1 #dnavaccines #dnamedicines
-
INOVIO Pharmaceuticals
@InovioPharma
INO-4800, INOVIO’s #covid19 DNA vaccine candidate, showed positive results in protecting non-human primates from a live virus challenge 13 weeks after the last vaccination. See the full release here: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
Dr. Kate Broderick, INOVIO SVP and R&D Lead, was interviewed in @TheHill about INOVIO’s contribution to the #covid19 vaccine race and what the world can expect from our #dnamedicines technology. Read more: thehill.com/homenews/coronavirus-report/509405-coronaviru… #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
The @US_FDA granted orphan drug designation to INO-3107, INOVIO’s DNA medicine being evaluated in a Phase 1/2 trial for treatment of recurrent respiratory papillomatosis (#rrp). Read more about what this designation means: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnamedicines #dnaimmunotherapies
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO will release second quarter 2020 financial results after market close on August 10, 2020, followed by a live conference call and webcast at 4:30pm ET. More information here: ir.inovio.com/news-releases/news-releases-details/2020/IN… $INO #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
Dr. Jeffrey Skolnik, INOVIO VP of Clinical Development, was interviewed by @AJMC_Journal in their #asco20 evidence-based #oncology feature. Read what he shared about INOVIO’s glioblastoma multiforme (#gbm) candidate here: www.ajmc.com/view/asco-2020-ajmctv-interviews #dnamedicines #dnaimmunotherapies
-
INOVIO Pharmaceuticals
@InovioPharma
Today on #gbmday, hear more about glioblastoma multiforme (#gbm) treatment considerations and the potential role of INOVIO’s #dnaimmunotherapy in this excerpt from our recent #dnamedicines webinar: www.youtube.com/watch?v=BAwnZZmVSTI
-
INOVIO Pharmaceuticals
@InovioPharma
We're proud to participate in the @IPVSociety #ipvc2020 conference to share data from our EACH-WOMAN project w/ @Optum on the effectiveness & safety of standard of care treatment for precancerous cervical dysplasia, often caused by #hpv 16/18 www.linkedin.com/posts/inovio-pharmaceuticals_ipvc-abstra… #dnamedicines
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO CEO Dr. J. Joseph Kim spoke with Bloomberg @BW on their #podcast about the Phase 1 interim data for our #covid19 DNA vaccine candidate and what’s next for Phase 2/3. Listen here: www.bloomberg.com/news/audio/2020-07-15/inovio-pharmaceut… #dnavaccines #dnamedicines
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO and @IVIHeadquarters in partnership with Seoul National University Hospital dosed the first patient in a Phase 1/2 clinical trial of INOVIO's #covid19 DNA vaccine candidate in South Korea. #dnavaccines #dnamedicines
INOVIO Pharmaceuticals
@InovioPharma
This is the first #covid19 vaccine clinical study approved in South Korea funded by @CEPIvaccines through INOVIO and supported by KCDC/KNIH. INOVIO recently disclosed positive interim results of its Phase 1 trial in the U.S. and plans to initiate a Phase 2/3 trial this summer.
-
INOVIO Pharmaceuticals
@InovioPharma
In our webinar, INOVIO CEO Dr. J. Joseph Kim and Dr. David Weiner, EVP and Director at @TheWistar, INOVIO Director, discussed the history of #dnamedicines and #dnavaccines, and what makes them unique. Watch here: www.youtube.com/watch?v=s0puWCg-uB4 #covid19 #immunooncology #cancer
-
INOVIO Pharmaceuticals
@InovioPharma
#icymi: In this video, Dr. Kate Broderick, INOVIO SVP and R&D Lead, speaks with Dr. Stanley Plotkin, Emeritus Professor and INOVIO Scientific Advisory Board Member, about the potential advantages of #dnavaccines in response to #covid19: www.youtube.com/watch?v=bByqxvm_M2Q #dnamedicines
-
INOVIO Pharmaceuticals
@InovioPharma
Dr. Kate Broderick, INOVIO SVP, R&D Lead, is encouraged by the interim Phase 1 data for INOVIO’s #covid19 DNA vaccine candidate. See what she said here in @SDUT: www.sandiegouniontribune.com/2020/06/30/inovios-covid-19-… #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
In this @NHKWORLD_news story, Dr. Kate Broderick, INOVIO SVP, R&D Lead, shares her reaction to positive interim Phase 1 data for INOVIO’s #covid19 DNA vaccine, along with what’s next for trials: www3.nhk.or.jp/nhkworld/en/news/20200701_19/ #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
In this @6abc story, learn about INOVIO’s COVID-19 DNA vaccine candidate selection for Operation Warp Speed and hear from CEO Dr. J. Joseph Kim about why he is optimistic about INOVIO's Phase 1 interim #covid19 data: 6abc.cm/3iffttv #dnavaccines #dnamedicines
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO CEO Dr. J. Joseph Kim spoke with the
@WSJ about positive Phase 1 interim data released yesterday for INOVIO’s #covid19 DNA vaccine candidate. Learn more here: (log-in required): www.wsj.com/articles/inovio-reports-positive-early-stage-… #dnamedicines
INOVIO Pharmaceuticals
@InovioPharma
See INOVIO’s SVP of R&D Dr. Kate Broderick discuss the development of INO-4800, INOVIO’s #covid19 DNA vaccine candidate, in this @WSJ video hosted by Daniela Hernandez, featuring Dr. Anthony Fauci and other leading scientists: www.wsj.com/video/the-promise-and-peril-of-fast-tracking-… #dnavaccines
#dnamedicines -
INOVIO Pharmaceuticals
@InovioPharma
Today INOVIO announced interim Phase 1 data for INO-4800, our COVID-19 DNA vaccine candidate & its selection in Operation Warp Speed. Learn more about the safety and preliminary response results, along with animal challenge data: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is excited to expand our leadership team with two new senior executives. This week we welcomed Gene Kim, President of INOVIO Asia and Dr. Mammen (Anza) Mammen, INOVIO Senior Vice President of Clinical Development: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO announced we’ve been awarded $71 million from the U.S. @DeptofDefense to support large-scale manufacturing of INOVIO’s CELLECTRA® 3PSP device, which is used to deliver INOVIO’s COVID-19 DNA vaccine candidate. Details: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO has moved into Phase 1/2 #clinicaltrials for INO-3107 and is seeking participants with HPV-6 and/or HPV-11 associated recurrent respiratory papillomatosis (RRP). For details, click here: clinicaltrials.gov/study/NCT04398433 #dnamedicines #dnaimmunotherapies
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO CEO Dr. J Joseph Kim was on an @IAmBiotech panel with experts from @JNJInnovation, @Chimerix, @Novartis, @ABatemanHouse & @ArthurCaplan to discuss bioethics through the lens of a pandemic. Watch on @StatNews: www.statnews.com/sponsor/2020/06/09/bioethics-through-the… #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO pairs rapid design and groundbreaking delivery to design urgently needed, effective #dnamedicines, including #dnaimmunotherapies & #dnavaccines. Learn how we’re using our approach to combat global health concerns on our YouTube channel: www.youtube.com/watch?v=uZJ25wZecTY #covid19
-
INOVIO Pharmaceuticals
@InovioPharma
We’re proud INOVIO’s DNA vaccine and our work to combat COVID-19 are featured in @IAmBiotech's #beyondimagination series blog post. Check it out here. bio.news #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
Tim Herring, MPH, INOVIO Senior Epidemiologist, presented at a virtual @JeffAcCommons seminar titled “COVID-19: Pharmaceutical Vaccine Development – General Process & Focus on a DNA-based Vaccine.” Watch here: jdc.jefferson.edu/covid-19-ssnv/5/ #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
In this video interview with @WIRED, INOVIO CEO Dr. J. Joseph Kim speaks with Dr. Seema Yasmin about INOVIO’s COVID-19 DNA vaccine candidate and updates on current trials: www.youtube.com/watch?v=hGrp5zsqi60&t=1s #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
In this @sdut article, learn more about the process of developing a #covid19 vaccine and what makes INOVIO’s COVID-19 DNA vaccine candidate stand out: www.sandiegouniontribune.com/2020/06/06/scientists-are-st… #dnavaccines #dnamedicines
-
INOVIO Pharmaceuticals
@InovioPharma
On June 11 at 9am PDT, INOVIO President and CEO Dr. J. Joseph Kim will speak at the Bioethics Through the Lens of a Pandemic panel session during @IAmBiotech Digital 2020. Register here: convention.bio.org #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
We’re excited to share further progress of INOVIO’s COVID-19 DNA vaccine candidate. In June, we’ll start the Phase 1/2 clinical trial in South Korea with support from @IVIHeadquarters and Seoul National University Hospital: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
Thank you to everyone who tuned in for our #dnamedicines webinar. If you missed it, click here to see the archived video and learn more about INOVIO: ir.inovio.com/events-and-presentations/default.aspx #dnavaccines #dnaimmunology
-
INOVIO Pharmaceuticals
@InovioPharma
Today at 10am EDT, INOVIO is hosting a #dnamedicines webinar. Tune in to hear from INOVIO leadership and world-renowned scientists about DNA Medicines: From COVID-19 to Cancer. us02web.zoom.us/webinar/register/9015901584191/WN_bV7Ldl3… #dnavaccines #dnaimmunotherapy #covid19
-
INOVIO Pharmaceuticals
@InovioPharma
Watch this video to see how INOVIO is powering #dnamedicines and #dnavaccines: www.youtube.com/watch?v=NCZG5paS2cA&t=4s #dnaimmunotherapy
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is focused on serving people with urgent health needs. One area we are studying is the role #dnamedicines can have for newly diagnosed glioblastoma patients. See our data: ir.inovio.com/news-releases/news-releases-details/2020/IN… #braintumorawarenessmonth #dnaimmunotherapy
-
INOVIO Pharmaceuticals
@InovioPharma
Learn more about how INOVIO is creating precisely designed plasmids with our technology: inovio.com/technology/about-dna-medicine/ #dnamedicines
-
INOVIO Pharmaceuticals
@InovioPharma
The @WHO and @CEPIVaccines selected two vaccine candidates for COVID-19 to be tested for efficacy in Australia. One of those is INOVIO’s DNA vaccine candidate for #covid19. Read more on @CSIRO’s blog. #dnavaccines #dnamedicines
CSIRO
@CSIRO
We're testing two vaccine candidates for COVID-19 at our Australian Centre for Disease Preparedness. Want to know what makes them so special?
#coronavirus #covid19 @CEPIvaccines @WHO @InovioPharma @UniofOxford
blog.csiro.au/two-vaccine-candidates-acdp/ -
INOVIO Pharmaceuticals
@InovioPharma
We’re working at unprecedented speeds to bring a #covid19 vaccine to market. #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
This is one advantage of INOVIO’s #dnamedicines.
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO’s #dnamedicines are made using a process called SynCon®. Learn more: inovio.com/technology/about-dna-medicine/
-
INOVIO Pharmaceuticals
@InovioPharma
Learn more about INOVIO’s #dnamedicines technology here: inovio.com/technology/about-dna-medicine/
-
INOVIO Pharmaceuticals
@InovioPharma
On Monday, June 1, INOVIO is hosting a #dnamedicines webinar: From COVID-19 to Cancer. Tune in at 10am EDT to hear from INOVIO leadership and world-renowned scientists. Details and registration are here: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnavaccines #covid19 #dnaimmunology
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced an INOVIO study published in peer-reviewed journal @NatureComms about the robust preclinical immune response, including both neutralizing antibodies and T cell responses, of INOVIO’s COVID-19 DNA vaccine: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals reposted
CSIRO
@CSIRO
Vaccines traditionally can take >10 years to develop. To fight COVID-19, researchers globally are embracing a new, accelerated model to ensure a safe and efficacious vaccine.
#coronavirus #covid19 @WHO @CEPIvaccines @InovioPharma @UQ_News @UniofOxford
www.csiro.au/Showcase/COVID-19-vaccine -
INOVIO Pharmaceuticals
@InovioPharma
INOVIO released data for newly diagnosed #glioblastoma multiforme (#gbm) patients who received our DNA medicine INO-5401 in combination w/ a PD-1 inhibitor. Results will be presented at #asco20 Virtual Scientific Program: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnamedicines #dnaimmunotherapy
-
INOVIO Pharmaceuticals
@InovioPharma
Today #inovio reported Q1 2020 financial results and important company updates about our DNA vaccines for COVID-19, and diseases associated with #hpv and #cancer. See results here: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnavaccines #dnamedicines $INO
-
INOVIO Pharmaceuticals
@InovioPharma
We published data from our completed Phase 1b study with INO-5150 that demonstrated a slowing of Prostate-Specific Antigen Doubling Time (PSADT), a measure of clinical impact, in men with biochemically relapsed prostate cancer. Link: www.cell.com/molecular-therapy-family/molecular-therapy/f… #dnamedicines
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO’s CEO Dr. J. Joseph Kim will participate in the COVID-19 (Vaccines and Monitoring) Panel Discussion during the Maxim Group Infectious Disease Virtual Conference on Tuesday, May 5th at 2:15 pm ET. For webcast details: go.pardot.com/l/652223/2020-04-02/j1mqg #covid19 #dnamedicines
-
INOVIO Pharmaceuticals
@InovioPharma
What used to take years, INOVIO is doing in months. In this @WashingtonPost article, read about how quickly we designed our #covid19 DNA vaccine candidate and what we’re doing to move forward with unprecedented speed: www.washingtonpost.com/science/2020/05/02/coronavirus-vac… #dnavaccines #dnamedicines
-
INOVIO Pharmaceuticals
@InovioPharma
With new funding from @CEPIVaccines, INOVIO will expand our existing DNA manufacturing agreement with Richter-Helm BioLogics to support large-scale manufacturing of our COVID-19 DNA vaccine candidate. Read more: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnavaccines #dnamedicines #covid19
-
INOVIO Pharmaceuticals
@InovioPharma
Today INOVIO and GeneOne Life Science announced positive interim data through week 16 of Phase 1/2a clinical data of INOVIO’s DNA vaccine INO-4700 for MERS #coronavirus. Read more here: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
We provided 40 healthy volunteers with the 1st dose of our #covid19 DNA vaccine candidate. With our Phase 1 U.S. clinical trial enrollment complete, interim immune responses & safety results are excepted in late-June. Read more: ir.inovio.com/news-releases/news-releases-details/2020/IN… #dnavaccines #dnamedicines
-
INOVIO Pharmaceuticals reposted
Mad Money On CNBC
@MadMoneyOnCNBC
"We expect to finish enrollment of all 40 volunteers before the end of April," Inovio Pharmaceuticals CEO Dr. Joseph Kim told @JimCramer. Inovio is one of two companies to initiate Covid-19 vaccine trials in the U.S. cnb.cx/2VxgXpC
-
INOVIO Pharmaceuticals
@InovioPharma
Eleven trial volunteers have been dosed with our #covid19 DNA vaccine candidate. Last night one of those volunteers was interviewed on @NBCNightlyNews. Watch the segment here to learn more about our #dnavaccines: www.youtube.com/watch?v=mhSc5hrSUpw #dnamedicines
-
INOVIO Pharmaceuticals reposted
Mad Money On CNBC
@MadMoneyOnCNBC
***TONIGHT 6p ET***
@JimCramer is going one-on-one with the CEO of @InovioPharma to hear more about the company’s recent efforts in the race to find a COVID-19 vaccine -
INOVIO Pharmaceuticals
@InovioPharma
Our CEO Joseph Kim was interviewed on PBS
@NewsHour sharing an update on our COVID-19 DNA vaccine candidate. Watch the segment and learn more about #dnamedicines here: www.pbs.org/newshour/show/we-need-a-vaccine-to-vanquish-c… #dnavaccines #covid19 -
INOVIO Pharmaceuticals
@InovioPharma
Today @IVIHeadquarters announced @CEPIVaccines granted funding to INOVIO to work with IVI and the Korea National Institute of Health for a Phase 1/2 clinical trial of our #covid19 DNA vaccine candidate in South Korea. Read more: ir.inovio.com/news-and-media/news/press-release-details/2… #dnamedicine #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
On Mon., April 6, we initiated our COVID-19 DNA vaccine Phase 1 clinical study with the first participant dosed with our investigational DNA vaccine INO-4800. Read more in @NYTimes (click control/command F + INOVIO to view): www.nytimes.com/2020/04/06/world/coronavirus-live-news-up… #dnavaccines #dnamedicines
-
INOVIO Pharmaceuticals
@InovioPharma
Today we initiated Phase 1 clinical testing of our #covid19 DNA vaccine INO-4800. Up to 40 healthy volunteers will participate at two locations. Read more about this significant step forward in the global fight against COVID-19: ir.inovio.com/news-and-media/news/press-release-details/2… #dnamedicines #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO is at the forefront of the fight against #covid19. In this @cenmag article, our CEO Joseph Kim talks about DNA vaccines and working to bring them to market: cen.acs.org/pharmaceuticals/vaccines/coronavirus-help-mRN… #dnavaccines #dnamedicines
-
INOVIO Pharmaceuticals
@InovioPharma
Our coronavirus R&D lead Dr. Kate Broderick participated in a press conference with the Mayor of San Diego about our progress on a #covid19 vaccine and how the world is coming together. #dnamedicines #dnavaccines
NBC 7 San Diego
@nbcsandiego
Two San Diego-based biotech companies are full steam ahead developing coronavirus vaccines that could help save millions of lives. on.nbc7.com/M8upg7F
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO today announced positive interim results with our lead DNA medicine candidate VGX-3100 from our Phase 2 study in patients with HPV-associated precancerous vulvar dysplasia. See the data here: ir.inovio.com/news-and-media/news/press-release-details/2… #hpv #dnamedicines #inovio #vulvardysplasia
INOVIO Pharmaceuticals
@InovioPharma
To learn more about our #dnamedicines, click here: www.linkedin.com/feed/update/urn:li:activity:664763422099… #inovio
-
INOVIO Pharmaceuticals
@InovioPharma
Last night on @CNN, Bill Gates discussed what the world is learning from #covid19 and how his foundation is helping companies like #inovio build DNA vaccines in a new way: www.youtube.com/watch?v=iNLiUN0l7ws #dnamedicines #dnavaccines
INOVIO Pharmaceuticals
@InovioPharma
Learn more about INOVIO’s approach to #dnamedicines here: www.linkedin.com/feed/update/urn:li:activity:664763422099… #inovio #dnavaccines
-
INOVIO Pharmaceuticals
@InovioPharma
$INO today announced positive interim results with our lead DNA medicine candidate VGX-3100 from our Phase 2 study in patients with HPV-associated precancerous anal dysplasia. See the data here: ir.inovio.com/news-and-media/news/press-release-details/2… #hpv #dnamedicines
-
INOVIO Pharmaceuticals
@InovioPharma
The Department of Defense awarded @OlogyBio a grant to partner with INOVIO to manufacture a #covid19 vaccine. Read more here: ir.inovio.com/news-and-media/news/press-release-details/2… $INO
-
INOVIO Pharmaceuticals reposted
60 Minutes
@60Minutes
After receiving COVID-19’s genetic sequence in January, Inovio Pharmaceuticals put it into their computer algorithm, which designed a vaccine on paper in just three hours. How long will it take before a vaccine is ready? www.cbsnews.com/news/inside-the-race-for-a-vaccine-to-pre…
This media couldn't be displayed. See it on the original post. -
INOVIO Pharmaceuticals reposted
60 Minutes
@60Minutes
Inovio Pharmaceuticals’ race to create a vaccine began when the genetic sequence of COVID-19 was posted online by Chinese scientists just weeks after the outbreak was identified. www.cbsnews.com/news/scientists-rush-to-develop-novel-cor…
This media couldn't be displayed. See it on the original post. -
INOVIO Pharmaceuticals
@InovioPharma
Proud to see our coronavirus R&D lead Dr. Kate Broderick on @60Minutes discussing INOVIO’s #dnamedicines & our efforts to develop a #dnavaccine vs. #covid19
-
INOVIO Pharmaceuticals reposted
60 Minutes
@60Minutes
Sunday on 60 Minutes: when will a vaccine to prevent COVID-19 — and an anti-viral drug to treat the disease — be ready? www.cbsnews.com/video/finding-a-covid-19-vaccine-and-drug…
-
INOVIO Pharmaceuticals reposted
Biocom California | Bay Area
@BiocominSF
Join us this Thursday, March 19, for a LIVE WEBINAR with Dr. Kate Broderick of @InovioPharma re: their development of a device for vaccine delivery to treat the coronavirus that causes COVID-19. Dr. Li Chen of @thermofisher will moderate. REGISTER: www.biocom.org/events/event/?event=Breakfast-With-Biocom-…
-
INOVIO Pharmaceuticals
@InovioPharma
INOVIO today reported financial results for the fourth quarter and year ended December 31, 2019. #inovio Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
INOVIO Pharmaceuticals
@InovioPharma
Join us for a live conference call and webcast at 4:30 p.m. Eastern Time. www.webcaster4.com/Webcast/Page/2021/33409
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced a $5M grant from the Bill & Melinda Gates Foundation to accelerate the testing and scale-up of our CELLECTRA® 3PSP smart device for the intradermal delivery of INO-4800, our DNA vaccine candidate for COVID-19. #inovio #covid19 Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals reposted
CEPI
@CEPIvaccines
We’re working with @InovioPharma to develop a vaccine against #covid19 💉
@ELLEmagazine speaks to Dr Kate Broderick about their rapid response to the outbreak 👩⚕️ #internationalwomensday
www.elle.com/culture/tech/a30766409/inovio-coronavirus-ka… -
INOVIO Pharmaceuticals
@InovioPharma
#inovio #ino $INO #covid19 #dna #dnamedicine
INOVIO Pharmaceuticals
@InovioPharma
-
INOVIO Pharmaceuticals
@InovioPharma
Highlighting International HPV Awareness Day, we are reminded of the urgent need to combat the human papillomavirus (HPV), a core focus for us at INOVIO. #hpv #inovio $INO Read more: www.linkedin.com/pulse/harnessing-power-dna-medicines-ino…
-
INOVIO Pharmaceuticals
@InovioPharma
After meeting with President Trump, Vice President Pence, and the U.S. Coronavirus Task Force at the White House, we announced an accelerated timeline for developing DNA vaccine INO-4800 to address COVID-19. $INO #inovio #covid19 Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Meg Tirrell
@megtirrell
Here’s who’s headed to the White House this afternoon for meeting on #covid19 vaccines and drugs
-
INOVIO Pharmaceuticals
@InovioPharma
We will report our 2019 fourth quarter and full year financial results on March 12, 2020. We will host a conference call and live webcast to provide a general corporate update and detail the results. $INO Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals reposted
Twist Bioscience
@TwistBioscience
We are proud to work with so many top notch customers and collaborators on #coronavirus.
@InovioPharma @EmilyLeproust #2019ncov #wemakedna
The global fight against coronavirus - BBC Future www.bbc.com/future/article/20200210-coronavirus-finding-a… -
INOVIO Pharmaceuticals
@InovioPharma
Today we announced that we received authorization from the U.S. FDA to begin a Phase 1/2 clinical trial for INO-3107, a DNA medicine to treat a rare disease -- Recurrent Respiratory Papillomatosis (RRP). $INO #hpv #rrp Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Today, data from our pilot clinical study of INO-3106, a DNA therapy targeting HPV 6 for the treatment of recurrent respiratory papillomatosis (RRP), was published in the open-access scientific journal Vaccines (MDPI). $INO #hpv #rrp Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
We are collaborating with Beijing Advaccine Biotechnology Co. to advance the development in China of INO-4800, our vaccine against the recently emerged strain of coronavirus (2019-nCoV). $INO #coronavirus Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals reposted
Bloomberg TV
@BloombergTV
Philadelphia-based biotech firm Inovio, with a $9 million grant, joins the race to create a coronavirus vaccine www.bloomberg.com/news/videos/2020-01-27/the-race-for-a-c…
This media couldn't be displayed. See it on the original post. -
INOVIO Pharmaceuticals reposted
The Wall Street Journal
@WSJ
Several drugmakers are racing to develop vaccines that could protect against the new respiratory virus originating in China, as fears mount it could spread more widely www.wsj.com/articles/drugmakers-rush-to-develop-vaccines-…
-
INOVIO Pharmaceuticals reposted
CEPI
@CEPIvaccines
Given the rapid global spread of the nCoV-2019 virus the world needs to act quickly and in unity to tackle this disease 🌏
We're funding three programmes to develop vaccines against the novel #coronavirus, nCoV-2019 👉cepi.net/cepi-fund-three-programmes-develop-vaccines-agai… -
INOVIO Pharmaceuticals
@InovioPharma
We have been selected by the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a vaccine against the recently emerged strain of coronavirus (2019-nCoV) that has killed numerous people and infected hundreds more in China to date. Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
We announced today the appointment of Jay Shepard to our Board of Directors. Mr. Shepard has broad healthcare and financial experience given his tenure as CEO of several biotech companies, multiple corporate board appointments and expertise as a healthcare venture capitalist.
INOVIO Pharmaceuticals
@InovioPharma
Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals reposted
CEPI
@CEPIvaccines
May saw our partners @InovioPharma launch the first in-human trial with their Lassa vaccine candidate🩺
Our Director of Vaccine R&D, Melanie Saville, said: “We welcome Inovio’s work which could pave the way to reducing the great suffering caused” 👉 cepi.net/cepi-partner-inovio-advances-lassa-fever-candida… -
INOVIO Pharmaceuticals
@InovioPharma
Today we announced clinical program updates for 2020. These updates will be presented at Biotech Showcase 2020 in San Francisco, CA on January 14, 2020. Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Dr. J. Joseph Kim, President and CEO, will present at the Piper Jaffray 31st Annual Healthcare Conference on Wednesday, December 4, 2019 at 12:30pm ET in New York, NY. Dr. Kim will provide an Inovio overview and business update. Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
We reported 2019 third quarter financial results today. We will be holding a webcasted conference call today at 4:30 pm ET. Webcast link: www.webcaster4.com/Webcast/Page/2021/32184
Read more about our Q3 2019 financial results: ir.inovio.com/news-and-media/news/press-release-details/2… -
INOVIO Pharmaceuticals reposted
EBD Group
@EBDgroup
This #bioeurope panel will focus on the business aspects of taking a molecule from the bench and into a partnership with #pharma. @dechertllp @InovioPharma @ShawnBridy @CellMedica @immatics @EMDGroup @BeiGeneUSA
-
INOVIO Pharmaceuticals
@InovioPharma
Parker Institute for Cancer Immunotherapy and The Cancer Research Institute unveiled a new platform clinical trial testing multiple combination treatments in metastatic castration-resistant prostate cancer during a poster session today (poster # P387) at #sitc2019.
INOVIO Pharmaceuticals
@InovioPharma
Read more about the trial at www.parkerici.org/clinical-trial/the-porter-trial/ and www.cancerresearch.org/blog/october-2019/porter-immunothe…
-
INOVIO Pharmaceuticals reposted
Parker Institute
@parkerici
We will present our Phase 1b platform study in metastatic #prostatecancer at #sitc2019 this Friday, Poster P387. Read about our PORTER clinical trial, which tests 3 #immunotherapy drug combos. @bmsnews @cancerresearch @inoviopharma @oncovir and CellDex www.parkerici.org/clinical-trial/the-porter-trial
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced key interim data from our Phase 2 glioblastoma multiforme (GBM) trial of INO-5401 + cemiplimab showing that 80% of MGMT gene promoter methylated patients and 75% of unmethylated patients were progression-free at six months. Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals reposted
Cancer Research Institute
@CancerResearch
Our Clinical Accelerator team unveils a new platform clinical trial, in collaboration with @parkerici and four pharmaceutical partners, testing multiple combination treatments in metastatic castration-resistant prostate cancer. #sitc2019 #pcsm www.cancerresearch.org
-
INOVIO Pharmaceuticals
@InovioPharma
We will report our 2019 third quarter financial results on November 12, 2019. We will host a conference call and live webcast to provide a general corporate update and detail the results. Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
We announced today that we and The Wistar Institute have received a $4.6 million NIH grant in support of innovative research to tackle antimicrobial resistance employing our DNA-encoded monoclonal antibodies platform. Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
We have completed enrollment in our open-label, 24 patient, Phase 2 trial of VGX-3100 for treating high-grade anal dysplasia. $INO #hpv Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals reposted
Scrip, Citeline Commercial
@PharmaScrip
Inovio Eyes Expanded Asian Opportunities, Presence Via Korea Dual Listing
insights.citeline.com/SC125696/Inovio-Eyes-Expanded-Asian… #pharmascrip -
INOVIO Pharmaceuticals
@InovioPharma
We reported 2019 second quarter financial results today. We will be holding a webcasted conference call today at 4:30 pm ET. A link to the webcast can be found at ir.inovio.com/investors/events/default.aspx.
Read more about our Q2 2019 financial results: ir.inovio.com/news-and-media/news/press-release-details/2… -
INOVIO Pharmaceuticals
@InovioPharma
We announced today the closing of a private placement in the form of convertible bonds with an aggregate principal amount of 18 billion Korean Won (KRW) (USD $15 million) issued to institutional investors led by Korea Investment Partners (KIP). Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
We will report our 2019 second quarter financial results on August 8, 2019. We will host a conference call and live webcast to provide a general corporate update and detail the results. $INO Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Positive data from the first-in-human Phase 1 trial of INO-4700 targeting Middle East Respiratory Syndrome Coronavirus (MERS) were published in The Lancet Infectious Diseases. $INO #mers Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
We are holding a conference call with analysts this morning at 8:00am ET to discuss our latest corporate update. $INO Visit our website to listen to the live webcast: ir.inovio.com/investors/events/default.aspx
-
INOVIO Pharmaceuticals
@InovioPharma
We announced today that we have updated our corporate strategy to focus on the commercial development of our late-stage HPV assets and reallocate capital to develop fast-to-market product candidates. $INO Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced that we have completed enrollment in our Phase 2 trial with VGX-3100 in patients with precancerous lesions of the vulva or vulvar intraepithelial neoplasia (VIN). Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced the complete enrollment of 198 participants for our pivotal Phase 3 registration trial ("REVEAL 1") of VGX-3100, a novel DNA-based immunotherapy being tested to treat cervical dysplasia caused by human papillomavirus (HPV). Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
We received an $8.14 million award from the U.S. Defense Threat Reduction Agency's (DTRA) Medical CBRN Defense Consortium to fund the further development of our new commercial intradermal delivery device, CELLECTRA 3PSP. Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals reposted
CEPI
@CEPIvaccines
Our partner @InovioPharma has launched the first in-human clinical trial to evaluate its Lassa candidate vaccine 👉 cepi.net/cepi-partner-inovio-advances-lassa-fever-candida…
#outsmartepidemics -
INOVIO Pharmaceuticals
@InovioPharma
Today we announced that we have dosed subjects in a Phase 1, first-in-human clinical trial to evaluate INO-4500, our DNA vaccine to prevent infection from the Lassa virus. Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
We are collaborating with @QIAGEN to co-develop a biomarker diagnostic test to identify patients most likely to respond to VGX-3100, our immunotherapy to treat advanced cervical dysplasia associated with the human papillomavirus virus (HPV). Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced a collaboration with Plumbline Life Sciences to co-develop a novel animal health vaccine for African swine fever (ASF) virus. Plumbline, based in South Korea, will fund all development and commercialization of the ASF vaccine. Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
We reported 2019 first quarter financial results today. We will be holding a webcasted conference call today at 4:30 pm ET. A link to the webcast can be found at ir.inovio.com/investors/events/default.aspx.
Read more about our Q1 2019 financial results: ir.inovio.com/news-and-media/news/press-release-details/2…. -
INOVIO Pharmaceuticals
@InovioPharma
Our lead Phase 3 product candidate, VGX-3100, has been granted an Advanced Therapy Medicinal Product Certificate from the European Medicines Agency for quality and non-clinical data. Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
We will report our first quarter 2019 financial results on May 9, 2019 at 4:30 pm ET. A live and archived version of the conference call will be available online at ir.inovio.com/investors/events/default.aspx. Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
dBiTEs generated potent anti-tumor activities and cleared established tumors in preclinical studies. These results were published in JCI Insight, a peer-reviewed journal published by the American Society for Clinical Investigation. Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals reposted
The Wistar Institute
@TheWistar
Congrats to @TheWistar’s Dr. Weiner & our partners at @InovioPharma for winning Best Therapeutic Vaccine Award at the #vieawards for their #hpv vaccine!
-
INOVIO Pharmaceuticals
@InovioPharma
VGX-3100, Inovio's Phase 3 HPV immunotherapy, was selected as "Best Therapeutic Vaccine" at World Vaccine Congress held this week in Washington D.C. Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced that we received a third milestone payment for development in a Phase 2 HPV-related cancer trial for MEDI0457 being conducted by AstraZeneca. Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Check out our new official Facebook page! Like and follow the page to receive updates on company progress and relevant industry news. www.facebook.com/InovioPharmaceuticals
-
INOVIO Pharmaceuticals
@InovioPharma
A toddler’s dwindling voice was chalked up to acid reflux. Her problem was far more serious. www.washingtonpost.com/national/health-science/a-toddlers…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced our new HPV therapy INO-3106 demonstrated clinical efficacy against rare respiratory tract tumors in a pilot clinical study. This adds to the breadth of HPV-related diseases that our technology can target. Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Preclinical cancer model shows tumor-clearing ability of our novel DNA-encoded Bi-specific T Cell Engagers (dBiTE) technology. Results were presented as a poster at the American Association for Cancer Research (AACR) Annual Meeting in Atlanta. Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Today we announced that our Phase 1/2 study for INO-5401 in newly diagnosed glioblastoma (GBM) has completed enrollment three months ahead of schedule! Read more: ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals to present at H.C. Wainwright Global Life Sciences Conference in London, UK $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio appoints global commercial leader to its Board of Directors $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio‘s Ebola vaccine delivered intradermally demonstrates 100% immunogenicity in a clinical study published in The Journal of Infectious Diseases $INO #ebola #vaccine ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals reposted
The Wistar Institute
@TheWistar
Congrats to Dr. David Weiner on the 2019 Scientific Achievement Award from @LifeSciencesPA! We @TheWistar are proud of you!
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals reports 2018 fourth quarter and year-end financial results $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio appoints Chief Operating Officer; announces strategic management changes $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals to announce fourth quarter and full year 2018 financial results and host conference call on March 12, 2019 $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Today is International HPV Awareness Day! HPV affects everyone, yet many people have never heard of it. It’s the most viral secret.
Start a conversation and help stop the spread of HPV. Learn more at www.askabouthpv.org. #hpvawarenessday #hpv #askabouthpv -
INOVIO Pharmaceuticals
@InovioPharma
Inovio initiates REVEAL 2 global Phase 3 clinical study for the treatment of HPV-related cervical pre-cancer $INO #hpv ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals completes sale of additional convertible senior notes $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio announces first subject dosed with its DNA-encoded monoclonal antibody (dMAb™) in first-ever human trial $INO #dmab ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio prices $65.0 million convertible senior notes offering $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio announces proposed convertible senior notes offering $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
"Inovio CEO Dr. Joseph Kim Pops By The Pub" - by Dr. KSS, MD, PhD (BioPub) $INO
biopubkss.com/index.php/2019/01/19/inovio-ceo-dr-joseph-k… -
INOVIO Pharmaceuticals
@InovioPharma
Inovio reports 2nd patient achieving full remission from HPV-related head & neck cancer after treatment with synthetic DNA vaccine and a PD-1 checkpoint inhibitor $INO #hpv #cancer #dna #immunotherapy #immunooncology ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals reposted
Nigeria Health Watch
@nighealthwatch
.@InovioIR @CEPIvaccines partnership demonstrates the confidence of both organizations in Inovio’s DNA vaccine platform to rapidly produce countermeasures against emerging viral threats potentially protecting large populations from a pandemic- Kate Broderick at #lic2019
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio's dMAb™ PD-1 checkpoint inhibitors demonstrate higher and more prolonged expression compared to native pembrolizumab and nivolumab sequences in preclinical studies $INO #dmab ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio's DNA-encoded monoclonal antibody (dMAb™) platform leaps forward with first-in-human trial $INO #dmab #zika ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio announces initiation of “MD Anderson’s HPV-Related Cancers Moon Shot” Phase 2 trial in new HPV indications $INO #hpv #cancer #moonshot ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio further demonstrates potency of its DNA-encoded monoclonal antibody (dMAb™) platform in three preclinical publications and prepares for first clinical trial in early 2019 $INO #dmab #dna #mab ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
DNA-encoded PCSK9 inhibitors may provide alternative for treating high cholesterol www.eurekalert.org/pub_releases/2018-11/twi-dpi111518.php via @TheWistar @EurekAlert #dna #dmab $INO
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio prepares for growth & commercialization with leadership appointments $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals reports 2018 third quarter financial results $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Op-ed by Dr. J. Joseph Kim: "Flu killed 65,000 people last year, but we don't seem to care" $INO #flu #virus #vaccine thehill.com/opinion/healthcare/415031-flu-killed-65000-pe…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals to participate in upcoming investment conferences $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio HIV vaccine PENNVAX®-GP delivered intradermally generated robust, long-term best-in-class antibody and T cell immune responses $INO #hiv ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals to report third quarter 2018 financial results on November 8, 2018 $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio presents progression free survival & PSA doubling time improvements in prostate cancer patients treated with INO-5150 $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio’s dMAb platform moves ahead with positive data, patents and grants $INO #dmab ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio’s Ebola vaccine provides 100% protection and elicits long-lasting immune responses in preclinical studies $INO #ebola #dna #vaccine ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio develops first DNA-encoded monoclonal antibody (dMAb™) checkpoint inhibitor and demonstrates tumor shrinkage in preclinical studies $INO #dmab ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Major cancer journal highlights data from an Inovio-sponsored trial in which a patient achieved full remission after dosing with DNA immunotherapy and checkpoint inhibitor $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
"Penn-led study raises hopes for vaccine to treat head and neck cancer"
$INO #hpv #immunotherapy #immunoonc #biotech
www2.philly.com/philly/health/penn-vaccine-head-and-neck-… -
INOVIO Pharmaceuticals reposted
Penn Medicine News
@PennMedNews
.@penncancer researchers have found that a therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus (HPV)-related head and neck cancer. dailym.ai/2prP41f Via @MailOnline #immunorevolution
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio develops novel H3N2 influenza DNA vaccine that generates cross-reactive responses and provides complete protection against lethal preclinical challenges $INO #h3n2 #flu #dna #vaccine ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals reposted
CEPI
@CEPIvaccines
A man has been diagnosed with #mers in South Korea, after returning from a trip to Kuwait via Dubai. This is the country’s first case of the infectious disease since 2015, when an outbreak killed 38 people and left millions reluctant to leave their homes. www.telegraph.co.uk/news/0/mers-case-revives-unhappy-memo…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio doses 1st subject in Phase 1/2 clinical trial for vaccine against deadly MERS infection $INO #mers ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio and Korean partner dose 1st subject in trial to develop world’s first vaccine to prevent hepatitis C infection $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals to participate in upcoming investment conferences $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio treats first patient in immuno-oncology study for advanced or metastatic bladder cancer in combination with Roche/Genentech’s atezolizumab $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio announces first patient dosed in trial to determine PENNVAX®-GP’s ability to induce remission of HIV infection $INO #hiv ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals reports 2018 second quarter financial results $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio partners with AIDS Malignancy Consortium to advance Inovio’s HPV therapy for high-grade anal dysplasia in HIV-positive patients $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals to report second quarter 2018 financial results on August 7, 2018 $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals reposted
CEPI
@CEPIvaccines
. @InovioPharma and CEPI are working to #outsmartepidemics by creating vaccines against Lassa fever and MERS www.fiercepharma.com/vaccines/back-themis-deal-inovio-nab… @FiercePharma
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio’s MERS vaccine generates high levels of antibodies and induces broad-based T cell responses in Phase 1 study $INO #mers ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio announces treatment of first patient in immuno-oncology study for glioblastoma (GBM) with INO-5401 in combination with Regeneron’s PD-1 inhibitor $INO #gbm ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio CEO to speak on viral epidemic preparedness panel at BIO International Convention $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
-
INOVIO Pharmaceuticals
@InovioPharma
(5/5) The new $100 million ATM filing plan would allow us to use the plan to sell at the market from time to time to extend our financial runway at a very efficient rate."
-
INOVIO Pharmaceuticals
@InovioPharma
(4/5) Similarly, the ATM plan is also a tool for financial planning. The last plan was filed for $50 million in June 2016 and of that total, less than $35 million was drawn down in 2 years.
-
INOVIO Pharmaceuticals
@InovioPharma
(3/5) financial planning and execution, and each shelf lasts for 3 years. The main reason we are filing this is because the current shelf expires on June 3, 2018. The previous $250 million shelf, for instance, we only used a little over $100 million.
-
INOVIO Pharmaceuticals
@InovioPharma
(2/4)...we are proactive on ensuring we have sufficient capital runway to support product and pipeline advancements and company growth.
Our latest filings allow us to continue this path. The new S3 Shelf registration is a tool we have had in place for over 8 years for... -
INOVIO Pharmaceuticals
@InovioPharma
May 28, 2018 - Note on Shelf
Overall, non-dilutive plans are still in place and of course the main preference for both the company and its shareholders. While we remain diligent on securing capital that doesn’t hinder shareholders best long-term interest, as a company,...(1/3) -
INOVIO Pharmaceuticals
@InovioPharma
Inovio opens Phase 2 trial for VGX-3100 in third indication to treat HPV – the No. 1 sexually transmitted disease $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio demonstrates PSA stabilizing effect of INO-5150 immunotherapy in Phase 1b study for prostate cancer $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals reports 2018 first quarter financial results $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio awarded up to $56 Million from CEPI to advance DNA vaccines against Lassa fever and MERS $INO #cepi ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio closes license and collaboration agreement with ApolloBio To develop and commercialize VGX-3100 in Greater China $INO #apollobio #immunotherapy #hpv ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals to report fourth quarter and year end 2017 financial results on March 14, 2018 $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio and The Wistar Institute receive more than $4.6 Million in R&D funding to advance vaccines against tuberculosis & malaria $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio's published universal flu vaccine data demonstrates protective responses against all major, lethal H1N1 influenza viruses from the last 100 years in animal models $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio’s co-founder along with its Lead Antigen Designer named among top 20 researchers with most granted U.S patents for 2016 $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio and the Parker Institute for Cancer Immunotherapy establish clinical development collaboration to evaluate novel cancer immunotherapy $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio receives milestone payment from MedImmune as MEDI0457 and checkpoint inhibitor combination trial in head and neck squamous cell cancer advances to phase 2 $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Enters License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio’s further analysis of VGX-3100 Phase 2b data reveals immune correlates and biomarker signatures that predicted clinical efficacy $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals SynCon® TERT cancer immunotherapy combined with checkpoint inhibitor synergistically shrinks tumor and improves survival in preclinical tumor model $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals presents immuno-oncology advancements at Society for Immunotherapy of Cancer conference $INO #sitc ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio initiates immuno-oncology clinical study for glioblastoma in combination with Regeneron’s PD-1 inhibitor $INO ir.inovio.com/news-and-media/news/press-release-details/2…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio and U.S. Army co-developing DNA vaccine that prevents lethal Lassa Fever infection in pre-clinical study $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio begins Phase 1b/2 trial combining INO-5401 with a PD-L1 checkpoint inhibitor in advanced bladder cancer $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio’s positive Zika vaccine clinical study data published in New England Journal of Medicine #zika $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio dMAb™ constructs shrink prostate tumors and protect against pseudomonas infection in preclinical studies $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio and partners initiate phase 1/2a trial to advance its vaccine against deadly MERS infection $INO #mers ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
INO-5150 slowed PSA rise and significantly increased PSA doubling times in recurrent prostate cancer patients $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals to participate in upcoming investment conferences #ino ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio to report second quarter 2017 financial results on August 8, 2017 $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio announces pricing of public offering of common stock $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio’s DNA-based monoclonal antibody platform achieves further proof-of-principle validation $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio announces leadership appointments $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals to participate on panel at 2017 BIO International Convention $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio fully enrolls 160 subjects in Puerto Rico for second Zika vaccine phase 1 trial $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio begins Phase 3 clinical trial of VGX-3100 for the treatment of HPV-related cervical pre-cancer $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio #zika Vaccine prevents persistence of virus and damage in male reproductive tract in pre-clinical study $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio announces collaboration for T-cell immunotherapy in combination with a PD-L1 checkpoint inhibitor $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio HIV vaccine elicits nearly 100% immune response rates in a clinical study $INO #hiv ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals reports 2017 first quarter financial results $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio provides update on MedImmune launch of combination trial for HPV-associated head & neck cancer $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio & Regeneron enter immuno-oncology clinical study agreement for Glioblastoma combination therapy $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio to participate in Bank of America Merrill Lynch 2017 Healthcare Conference $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio to report first quarter 2017 financial results on May 10, 2017 $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio initiates Phase 2 efficacy trial with VGX-3100 for HPV-related vulvar pre-cancers $INO #vin ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Ebola vaccine demonstrates robust immune responses with favorable safety profile in expanded P1 trial $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio and collaborators receive NIH grant to evaluate HIV immunotherapy PENNVAX®-GP $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
George Bickerstaff elected to Inovio’s Board of Directors $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio reports 2016 fourth quarter and year end financial results $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio to report fourth quarter and year end 2016 financial results on March 15, 2017 $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio’s SynCon® WT1 cancer antigen breaks tolerance, highlights potential for universal cancer immunotherapy $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio and ApolloBio to collaborate on development and commercialization of VGX-3100 in Greater China $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio to participate in upcoming investment conferences $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio's #zika vaccine generates robust immune responses in first human study $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio awarded $6.1M sub-grant through Wistar Institute to develop DNA-based monoclonal antibodies against Zika $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio’s co-founder and chair of its Scientific Advisory Board selected as a Top 20 Translational Researcher $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio #cancer #immunotherapy INO-3112 generates T cell immune responses in HPV head and neck cancer patients $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio #zika vaccine protects animals from infection, brain damage and death $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals to participate in upcoming investment conferences $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals to report third quarter 2016 financial results on November 9, 2016 $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio announces FDA Request for additional information for phase III program; trial initiation delayed $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio expands executive team to advance its DNA immunotherapy product portfolio $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio licenses veterinary foot and mouth disease vaccine to Plumbline Life Sciences $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio expands positive phase I #ebola vaccine trial to identify most optimal immunization regimen $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio reports 2016 second quarter financial results $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio appoints Dr. Ami Shah Brown as Vice President of Regulatory Affairs $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio will independently develop hepatitis B immunotherapy $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio doses first subject in #zika vaccine clinical trial $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio to report second quarter 2016 financial results on August 8, 2016 $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio deploys DNA-based monoclonal antibody technology in quest to cure HIV $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio's Zika vaccine phase I human trial approval was from the U.S. FDA. ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio and GeneOne Life Science receive approval for first-in-man Zika vaccine clinical trial $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio's Zika vaccine produces robust immune responses in non-human primates $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio Pharmaceuticals to Present at #ubs Global Healthcare Conference $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio reports 2016 first quarter financial results $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio showcases its broad pipeline of DNA-based immunotherapies, vaccines and dMAbs at the ASGCT $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio completes acquisition of needle-free injection technology $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio partners with NCI and Mayo Clinic to initiate Hepatitis C immunotherapy clinical trial $INO #hcv ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio to report first quarter 2016 financial results May 9, 2016 $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio #ebola vaccine generates robust immune responses in humans $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio #hpv Immunotherapy Selected as “Best Therapeutic Vaccine” by World Vaccine Congress $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
CHIKV DNA monoclonal antibody and DNA vaccine ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio’s DNA-based monoclonal antibody+DNA vaccine provide 100% protection against lethal #chikungunya challenge in preclinical study $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio acquires needle-free injection technology to advance strategy for next-generation vaccines $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio reports 2015 fourth quarter and year end financial results $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio appoints DNA immunotherapy pioneer David B. Weiner, Ph.D., to its Board of Directors $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio to report 4Q and year end 2015 financial results on March 14 $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio's DNA vaccine for #zika virus induces robust immune responses in preclinical study $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio to participate in upcoming investor conferences $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio and GeneOne Life Science initiate patient recruitment for #mers vaccine trial $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio awarded grant to advance needle-free #vaccine delivery device $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio will present at Biotech Showcase 2016 on January 12 at 9:30 AM PST ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio adds Dr. Prakash Bhuyan to VGX-3100 leadership team for #hpv-related dysplasia ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio to present at Piper Jaffray #healthcare Conference Dec. 2 at 3:30PM ET ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
INO-3112 shows robust immune responses in patients w/head & neck #cancer. Results to be presented at #sitc & #esmo ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio will host its 3Q 2015 financial results conference call Monday, November 9 at 8:30 AM ET ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio and GeneOne advance #mers #vaccine ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio to participate in upcoming #aegis, #brean and #stifel #healthcare conferences ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio receives $24 million option grant from #darpa to advance #ebola program development ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio publishes successful phase 2b trial results of its #hpv #immunotherapy in The #lancet ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio's COO selected by #pharmavoice as one of the most #inspirational #leaders in the life #sciences industry ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio announces first patient dosed with universal #hiv #vaccine ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio to participate in #citi and #rodman & Renshaw #investor conferences $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio’s DNA #vaccine protects 100% against deadly #mers virus in non-human primates ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio reports 2015 2Q results ir.inovio.com/news/news-releases/news-releases-details/20…. Our conference call will discuss our new #cancer partnership www.investornetwork.com/event/presentation/174125
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio enters into strategic #cancer vaccine collaboration & license agreement with #medimmune ir.inovio.com/news/news-releases/news-releases-details/20… $INO #immunoonc
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio will hold its 2Q 2015 #financial results conference call on August 10, 2015 at 8:30 AM ET ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio’s #dna-based monoclonal antibody protects animals against lethal #dengue challenge ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio initiates clinical trial of INO-5150 DNA immunotherapy for #prostate #cancer ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio and the #eortc to collaborate on large phase II #cervical #cancer trial ir.inovio.com/news/news-releases/news-releases-details/20… #hpv
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio’s CEO appointed to Aspen Institute’s #health Innovators Fellowship ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio CEO Named "Entrepreneur of the Year" by Ernst & Young ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio partners with GeneOne Life Science for #mers #immunotherapy clinical development ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio to present at Jefferies #healthcare Conference June 4 at 8:30 AM ET ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio initiates clinical trial with DNA #immunotherapies to prevent and treat #ebola ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
2015 first quarter #financial results ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio closes $87.4 million underwritten financing ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals reposted
Kevin Brady
@RepKevinBrady
Amazing time @VGXI learning about efforts to create treatment and prevention approaches against Ebola. @InovioPharma
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio will report its first quarter 2015 #financial results May 11, 2015 ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio announces pricing of public offering of common stock ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio announces public offering of common stock ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio & @Roche initiate clinical trial for Inovio's #dna #immunotherapy to treat chronic #hepatitis B infection ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio’s #hpv #immunotherapy recognized as “Best Therapeutic Vaccine” by World Vaccine Congress ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio’s #hpv immunotherapy activates robust in vivo T cell responses in head & neck #cancer patients ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio selected by #darpa to lead $45M program to expedite development of novel products to prevent & treat #ebola ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio will be presenting at Alliance Regenerative #medicine's 2015 Regen Med #investor Day ir.inovio.com/news/news-releases/news-releases-details/20… @alliancerm #rmday15 $INO
-
INOVIO Pharmaceuticals
@InovioPharma
Scott M. White appointed Vice President, Clinical Development -- Infectious Diseases ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio and academic collaborators receive $16 million #hiv grant from #niaid ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio reports 2014 fourth quarter and year end #financial results ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
We will report our fourth quarter and year end 2014 #financial results on March 16, 2015 ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio welcomes Nancy Wysenski to its Board of Directors ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio to present at the Emerald Groundhog Day #investment Forum and #bioceo & Investor Conference www.globenewswire.com/news-release/2015/02/02/702023/1011… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
Dr. Mark Gelder has been appointed to lead clinical development of Inovio’s cervical dysplasia and #cancer programs ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio’s CEO, Dr. Joseph Kim, will present at the 2015 Biotech Showcase Conference ir.inovio.com/news/news-releases/news-releases-details/20… #bts15 $INO
-
INOVIO Pharmaceuticals
@InovioPharma
HIV #immunotherapy shows characteristics considered vital to treating #hiv ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio initiates #dna immunotherapy trial for breast, lung and pancreatic #cancers ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio appoints Zane Yang, M.D. Vice President, Clinical Development, #oncology ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio added to #nasdaq Biotechnology Index ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio will ring the Opening Bell Nov 25th on the #nasdaq Stock Market $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#melanoma DNA #immunotherapy inhibits tumor growth & increases survival in preclinical study $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio will independently develop its prostate cancer immunotherapy. It will maintain collaboration w/Roche for hep B ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio will present at the upcoming Stifel, Brean Capital, and Piper Jaffray investor conferences ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio reports 2014 third quarter financial results ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio will report its third quarter 2014 #financial results on November 10, 2014 ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio, #medimmune & the University of Pennsylvania partner to combat #influenza & antibiotic resistant bacteria ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
CEO Dr. Joseph Kim was featured on #cnbc discussing #inovio’s #ebola #dna immunotherapy cnb.cx/1rGM3EM $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio appoints Vice President of Commercial Development ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio’s #ebola vaccine moving into human trial with GeneOne Life Science $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio expands #hpv immunotherapy development to aerodigestive #cancers ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio CEO Dr. Joseph Kim will present at BioCentury's NewsMakers Conference & Bernstein's Genes as Drugs Event ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio begins trading on #nasdaq Global Select Market Exchange today $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Read why #inovio CEO believes #dna #immunotherapies could be a powerful weapon in the war against #cancer www.hugedomains.com/domain_profile.cfm?d=futureofcancerca…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio to list on #nasdaq ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio to present at upcoming Rodman & Renshaw #investment Conference & Aegis Capital #healthcare Conference $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Tune into our 2Q 2014 financial results conference call at 9AM ET to hear Dr. Kim discuss plans for VGX-3100 www.investornetwork.com
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio reports 2014 2Q financial results & plans to advance VGX-3100 into phase III ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#drexel University researcher: #inovio #dna vaccine protects animals against challenging C. difficile bacteria www.newsworks.org/index.php/local/item/71038-drexel-resea… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio will host its second quarter 2014 financial results call on August 11 $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Per protocol analysis measured subjects who received 3 doses of a 3-dose regimen; an ITT also achieved statistical significance $INO #inovio
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio's #hpv immunotherapy achieves primary efficacy endpoint in phase II cervical dysplasia trial $INO ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio added to Russell Global, Russell 2000® and Russell Microcap® Indexes ir.inovio.com/news/news-releases/news-releases-details/20… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio initiates #cervical #cancer clinical trial ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Watch our new #video, How Inovio's DNA Vaccines are Delivered, to learn how our #electroporation technology works inovio.com/resources/video-gallery/
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio broadens its intellectual property portfolio from the University of Pennsylvania ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio to present at upcoming #healthcare conferences ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio initiates immune therapy trial for head & neck #cancer caused by #hpv ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio subsidiary sells animal health assets ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio’s #dna-based monoclonal antibody therapy completely protects animals from lethal viral challenge ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
CEO Dr. Joseph Kim and Dr. David Weiner discuss #mers on #cbs News cbsloc.al/1m5jGNF
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio celebrated the opening of its San Diego Research Center www.youtube.com/watch?v=pRHw_z-zudk
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio CEO, Dr. Joseph Kim, will be presenting at Jefferies 2014 Global #healthcare Conference ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio acquires DNA therapies to generate iTreg targeting #alzheimers & #multiplesclerosis ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio reports 1Q 2014 #financial results ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio to report first quarter 2014 financial results on May 12, 2014 ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio continues building its senior team with the appointment of VP of Quality ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio wins Best Therapeutic Vaccine,Best Vaccine Licensing Deal & Best Early Stage Biotech @ World Vaccine Congress ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio reports 2013 fourth quarter and year end #financial results: ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio to report fourth quarter & year end 2013 #financial results on March 17, 2014 ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio closes $63.3 million underwritten financing ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio announces pricing of public offering of common stock ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio announces public offering of common stock ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio to present at Cowen & Company 34th Annual Health Care Conference ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio scientific advisors & board member discuss #dna immunotherapy potential youtu.be/HgWZh_abG3U
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio bolsters research & clinical development leadership ir.inovio.com/news/news-releases/news-releases-details/20…
-
INOVIO Pharmaceuticals
@InovioPharma
Dr. Kim, on #takingstock at 3PM EST today, will discuss why he expects 2014 be transformative for Inovio www.bloomberg.com/radio/
-
INOVIO Pharmaceuticals
@InovioPharma
CEO Dr. Joseph Kim provides a brief overview of #inovio and discusses what's to come in 2014 www.youtube.com/watch?v=YFqnIWtElm0
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio to present at BIO CEO & Investor Conference ir.inovio.com/2014-01-30-Inovio-Pharmaceuticals-to-Presen… #bioceo
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio unveils potent new immune activator ir.inovio.com/2014-01-23-Inovio-Pharmaceuticals-Unveils-P…
-
INOVIO Pharmaceuticals
@InovioPharma
#inovio CEO Dr. Kim featured in USA Today usat.ly/1cNXVKD @usatoday
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio’s hope for defeating cancer: inovio.com/resources/video-gallery/ #cancer #inovio #immunotherapies
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio to present at Biotech Showcase 2014 investor conference ir.inovio.com/2014-01-06-Inovio-Pharmaceuticals-to-Presen… #inovio
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio’s DNA vaccine for the deadly MERS virus induces robust immune response in preclinical trial bit.ly/1ehVjbl #inovio #mers
-
INOVIO Pharmaceuticals
@InovioPharma
CEO Dr. Joseph Kim appointed to the International Vaccine Institute Board of Trustees bit.ly/1aDuBID #inovio #dnavaccines #vaccines
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio to present at upcoming investor conferences bit.ly/1byc6mt #inovio #ldmicro #piperjaffray #breancapital
-
INOVIO Pharmaceuticals
@InovioPharma
CEO, Dr. Joseph Kim, receives 2013 Drug Discovery & Achievement Award bit.ly/1j7bzMr #inovio
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio reports 2013 3rd quarter financial results #earnings #inovio bit.ly/16Ytfrp
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio to report third quarter 2013 financial results on November 12, 2013 bit.ly/18Ssv3E #earnings #inovio
-
INOVIO Pharmaceuticals
@InovioPharma
Therapeutic vaccine for hepatitis C enters phase I clinical trial bit.ly/1b6IfTe #dnavaccine #hepatitisc
-
INOVIO Pharmaceuticals
@InovioPharma
Ever wondered how #inovio designs its DNA vaccines? Find out in our new Video Gallery: bit.ly/1fOBxrP
-
INOVIO Pharmaceuticals
@InovioPharma
Dr. Kim to participate in immunotherapy panel & present at the 12th Annual BIO Investor Forum bit.ly/19UisgD #bif13 #inovio
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio targets transformation of monoclonal antibody therapies bit.ly/19wiM55
-
INOVIO Pharmaceuticals
@InovioPharma
Roche & Inovio partner on prostate cancer & hep B immunotherapy products bit.ly/13FkMrz. Webcast @ 8AM ET bit.ly/15MCdnr
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio to present at the Rodman & Renshaw and Stifel Nicolaus Weisel investor conferences bit.ly/14nmlHN $INO
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio’s malaria DNA vaccine demonstrates robust immune responses in animal models #dnavaccine #malaria bit.ly/17PvvxA
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio has deleted a previous post linking to a SeekingAlpha article. Inovio does not endorse or refute third party opinions or articles.
-
INOVIO Pharmaceuticals
@InovioPharma
@InovioPharma's #cancer #vaccine induces T-cells with tumor-killing function & increases animal survival $INO proactivecapital.com/2013/07/24/inovio-pharmaceuticals-po…
-
INOVIO Pharmaceuticals
@InovioPharma
@InovioPharma's DNA therapy technology enhances blood vessel growth, and can treat peripheral arterial disease proactivecapital.com/2013/07/18/synthetically-optimized-h… $INO
-
INOVIO Pharmaceuticals
@InovioPharma
@InovioPharma's technology shows best in-class results in #hiv #vaccine study proactivecapital.com/2013/07/10/inovios-cellectra-electro… $INO #biotech
-
INOVIO Pharmaceuticals
@InovioPharma
@InovioPharma H7N9 DNA vaccine protects 100% of vaccinated animals in challenge study bit.ly/16iKb7z #dnavaccine #h7n9 #influenza
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio has an updated investor presentation: bit.ly/14ztfKO #dnavaccine #inovio #biotech
-
INOVIO Pharmaceuticals
@InovioPharma
@InovioPharma to present at #onemedforum Investor Conference (June 26-27th) in NY www.prnewswire.com via @PRNewswire $INO
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio to Present at OneMedForumNY 2013 Investor Conference bit.ly/11psG7B #inovio #dnavaccine #investorconferences
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio's influenza DNA vaccine generates first protective antibody responses.bit.ly/1bEqIRI
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals DNA Vaccine Provides Complete Protection in Preclinical Challenge Study proactivecapital.com/2013/05/14/inovio-pharmaceuticals-dn…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals Reports 2013 First Quarter Financial Results
proactivecapital.com/2013/05/10/inovio-pharmaceuticals-re… -
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses
proactivecapital.com/2013/04/18/inovio-pharmaceuticals-un… -
INOVIO Pharmaceuticals
@InovioPharma
Inovio's Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses in Phase I Study bit.ly/XIFRy4
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals Recognized With “Best Therapeutic Vaccine” and “Best Early Stage Biotech” Awards
proactivecapital.com/2013/04/18/inovio-pharmaceuticals-re… -
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant to Further Develop Mass Vaccination Device
proactivecapital.com/2013/04/10/inovio-pharmaceuticals-u-… -
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals Reports 2012 Fourth Quarter and Year End Financial Results proactivecapital.com/2013/03/18/inovio-pharmaceuticals-re…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals Prices $15.1 Million Offering of Common Stock and Warrants proactivecapitalgroup.com/2013/03/07/inovio-pharmaceutica…
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio Pharmaceuticals to Present at the Cowen & Company Health Care Conference proactivecapitalgroup.com/2013/02/27/inovio-pharmaceutica…
-
INOVIO Pharmaceuticals
@InovioPharma
Dr. Joseph Kim provides insight as to what’s to come in 2013 bit.ly/TwE2F9
-
INOVIO Pharmaceuticals
@InovioPharma
Inovio is dedicated to revolutionizing medicine's most powerful innovation. Check out their introductory video. bit.ly/XDNdkc







































































































































































































































































































































































